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Abstract
Overexpression of the centrosome-associated serine/
threonine kinase Aurora Kinase A (AURKA) has been
demonstrated in both advanced prostate cancer and
high-grade prostatic intraepithelial neoplasia lesions.
The single-nucleotide polymorphism T91A (Phe31Ile)
has been implicated in AURKA overexpression and has
been suggested as a low-penetrance susceptibility al-
lele in multiple human cancers, including prostate can-
cer. We studied the transcriptional consequences of
the AURKA Ile31 allele in 28 commercial normal pros-
tate tissue RNA samples (median age, 27 years). Sig-
nificant overexpression of AURKA was demonstrated
in homozygous and heterozygous AURKA Ile31 pros-
tate RNA (2.07-fold and 1.93-fold, respectively; P < .05).
Expression levels of 1509 genes differentiated between
samples homozygous for Phe31 alleles and samples
homozygous for Ile31 alleles (P = .05). Gene Ontology
classification revealed overrepresentation of cell cycle
arrest, ubiquitin cycle, antiapoptosis, and angiogenesis-
related genes. When these hypothesis-generating results
were subjected to more stringent statistical criteria, over-
expression of a novel transcript of the natural killer tu-
mor recognition sequence (NKTR) gene was revealed
and validated in homozygous Ile31 samples (2.6-fold;
P < .05). In summary, our data suggest an association
between theAURKA Ile31 allele and an altered transcript-
ome in normal non-neoplastic prostates.
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Introduction
Prostate cancer is the most commonly diagnosed neoplasia
among men in the western world. Although genetic predis-
position to prostate cancer has been well established,
identification of alterations in highly penetrant genes in only
a small proportion of patients suggests a role for multiple
low-penetrance susceptibility alleles in disease risk [1].
We have previously demonstrated an association be-
tween significant overexpression of the Aurora Kinase A
(AURKA; MIM 603072) gene, located on chromosome
20q13.2, and prostate cancer and metastases [2]. AURKA
encodes a centrosome-related serine/threonine kinase and
is frequently amplified and/or overexpressed in additional
human cancers and cell lines, including those of the breast,
ovary, bladder, pancreas, colon [3], and soft tissue [4]. In-
creased AURKA expression has also been reported in prema-
lignant breast [5] and prostate [6] lesions. Forced AURKA
overexpression in mammalian cell lines induces centrosomal
amplification, impaired chromosomal segregation, aneuploidy,
and transformation [7–9], suggesting an association between
enhanced AURKA expression and molecular mechanisms
underlying tumorigenesis.
A single-nucleotide polymorphism (SNP), T91A, resulting in
Phe31Ile amino acid substitution has been implicated in
AURKA overexpression. AURKA Phe31Ile allelic variant fre-
quencies vary among different ethnic populations worldwide.
The frequency ofAURKA Ile31 in healthy populations is highest
in Asians, followed by Hispanics, Caucasians, and African
Americans (0.62, 0.33, 0.21, and 0.13, respectively) [10–13].
None of these populations deviated from allele frequencies
expected from the Hardy-Weinberg equilibrium. The Ile31
variant is preferentially amplified, is associated with the degree
of aneuploidy in human tumors, and has a more potent trans-
forming capacity when compared to AURKA Phe31, inducing
cell growth in vitro and enhancing tumorigenicity in nude mice
[14]. Cumulative evidence suggests that AURKA 91A (Ile31) is
a low-penetrance tumor-susceptibility allele, predisposing both
homozygous and heterozygous carriers to an increased risk of
developing multiple human cancers, including prostate cancer
[10–12,15–17]. The significance and impact of this variant in
non-neoplastic human tissues has not been reported.
Because complex molecular changes associated with tumor-
igenesis may hinder the study of AURKA Ile31 overexpression,
we hypothesize that studying cellular transcriptome in non-
neoplastic tissues will provide an improved model for exploring
the influence of this genetic variant on the prostate.
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Materials and Methods
Commercial Prostate RNA and Tumor Models
Twenty-eight RNA samples from donor prostate tissues
classified as normal prostate were purchased: 27 samples
from donors of Asian descent (BioChain Institute, Inc., Hay-
ward, CA) and 1 sample from a donor of Caucasian descent
(Ambion, Inc., Austin, TX). The age range of donors was 20
to 71 years (average, 35 years; median, 27 years). The ages
of the donors are presented in Table W1. All purchased
human tissue samples were collected with informed consent
from the donors and their relatives.
DNA and RNA were also generated from three human
prostate cancer xenografts: WISH-PC14 and LuCaP35
(human androgen–dependent prostate-specific antigen–
secreting prostatic adenocarcinoma xenografts that have
been described previously) [2,18] and WM2.C (a prostatic
adenocarcinoma xenograft established and provided by
Z. Eshhar of the Weizmann Institute, Rehovot, Israel).
Genotyping
The 28 RNA samples were genotyped for AURKA T91A
(Phe31Ile) and G169A (Val57Ile) sequence alterations.
cDNA was prepared using random primers in accordance
with the manufacturer’s instructions (Invitrogen Life Technol-
ogies, Carlsbad, CA). All polymerase chain reaction (PCR)
primer pair sequences were determined based on the
reported transcribed sequence of AURKA (Table 1A). PCRs
were performed with StartFast Taq Polymerase in accor-
dance with the manufacturer’s instructions (Roche Diagnos-
tics, Mannheim, Germany) using a Biometra PCR system
(Biometra GmbH, Go¨ttingen, Germany). cDNA was ampli-
fied to generate a 427-bp amplicon using an AURKA Ex2–
Ex5–specific primer pair (Table 1A). PCR products were
digested with XapI (Fermentas Life Sciences, Hanover, MD)
in accordance with the manufacturer’s recommendations
and were analyzed by 4% agarose gel electrophoresis.
The wild-type AURKA 91T allele was digested to 276- and
151-bp fragments, whereas in the presence of 91A alter-
ation, the 151-bp fragment was further digested to 87- and
64-bp fragments. For confirmation, PCR products were se-
quenced using BigDye Terminator Chemistry (Applied Bio-
systems, Foster City, CA) and analyzed using an automated
ABI Prism 310 Genetic Analyzer (Applied Biosystems). The
G169A (Val57Ile) status of these samples was determined
according to the sequence obtained. To confirm the homo-
geneity of homozygous cDNA fragments, we further per-
formed denaturing high-performance liquid chromatography
(DHPLC) analysis using a WAVE apparatus (Transgenomic,
Inc., Omaha, NE), as previously described [19].
Quantitative Real-Time PCR
Real-time polymerase chain reaction (RT-PCR) analyses
were performed to determine the expression of AURKA, nat-
ural killer tumor recognition sequence (NKTR; MIM 161565),
cyclin-dependent kinase inhibitor 1C (CDKN1C; MIM 600856),
Table 1. Primers and Reaction Conditions.
(A) RT-PCR Analysis
Cycling Conditions (jC; sec)
Gene (GO No.) Primers Denaturation Annealing Elongation
AURKA Ex2–Ex5 (3213196) F: 5V-GGACCGATCTAAAGAAAACTGC-3V 95; 20 60; 20 72; 30
R: 5V-CTTTCCTTTACCCAGAGGGCG-3V
AURKA Ex2–Ex3 (3213196) F: 5V-GGACCGATCTAAAGAAAACTGC-3V 95; 20 63; 20 72; 30
R: 5V-CAAGACCCGCTGAGCCTGGCC-3V
NKTR Ex6– Int6a (5923890) F: 5V-CTCAAACATGACAGAGCGTTCC-3V 95; 20 60; 20 72; 20
R: 5V-AAAGAGAGAGAGAGCCTTAGAG-3V
NKTR Ex6–Ex8a (5923890) F: 5V-CTCAAACATGACAGAGCGTTCC-3V 95; 20 60; 20 72; 20
R: 5V-CCAGAAATAACCAGTCCAAAGAC-3V
NKTR Ex1– Int6b (5923890) F: 5V-CCAGCCAGCTCTTGCCGCCA-3V 95; 20 60; 20 72; 40
R: 5V-CCACCAGAAGATGTACAGGAAC-3V
NKTR Ex1–Ex8b (5923890) F: 5V-CCAGCCAGCTCTTGCCGCCA-3V 95; 20 62; 20 72; 40
R: 5V-GCTTGCAGCATCGGTCTTCAG-3V
GAPDH (83641890) F: 5V-CCAGAACATCATCCCTGC-3V 95; 20 60; 20 72; 20
R: 5V-GGAAGGCCATGCCAGTGAGC-3V
(B) Quantitative RT-PCR Analysis
Cycling Conditions (jC; sec)
Gene (GO No.) Primers Annealing Elongation Acquisition
AURKA Ex2–Ex5 (3213196) F: 5V-GGACCGATCTAAAGAAAACTGC-3V 63; 10 72; 11 84; 5
R: 5V-CTTTCCTTTACCCAGAGGGCG-3V
CDKN1C (4557440) F: 5V-CGCGGCGATCAAGAAGCTG-3V 68; 4 72; 10 92; 5
R: 5V-CCTCGGGGCTCTTTGGGCTC-3V
BAX (34335114) F: 5V-CCAGCAAACTGGTGCTCAAGG-3V 64; 10 72; 10 87; 5
R: 5V-CAACCACCCTGGTCTTGGATC-3V
NKTR Ex6– Int6a (5923890) F: 5V-CTCAAACATGACAGAGCGTTCC-3V 58; 10 72; 10 79; 5
R: 5V-AAAGAGAGAGAGAGCCTTAGAG-3V
NPC1 (89242153) F: 5V-TGGGCGCGATATTTCTGGTG-3V 68; 5 72; 9 87; 5
R: 5V-CTCCACGCGGCTGCCTTTC-3V
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BCL2-associated X protein (BAX; MIM 600040), and Nie-
mann-Pick disease type C1 (NPC1; MIM 607623) genes in
normal prostate RNA samples. All primers were designed to
include the exon–intron junction to avoid possible contamina-
tion of genomic DNA. Amplifications were carried out using
LightCycler (Roche Biochemicals, Mannheim, Germany), as
described previously [4]. Briefly, a total reaction volume of
10 ml contained FastStart Master mix (Roche Biochemicals,
Mannheim,Germany), 3mMMgCl2, and0.5 mMof each primer
(see Table 1B for primer sequences and reaction conditions).
Fluorescence quantification was calculated using LightCycler
software3.01 (RocheBiochemicals). TheexpressionofAURKA,
NKTR,CDKN1C, andBAX genes was normalized as described
previously [4] using NPC1 expression levels.
Affymetrix GeneChip Expression Analysis
RNA samples from normal prostate tissue—three sam-
ples homozygous for the AURKA Phe31 allele and five
samples homozygous for the AURKA Ile31 allele—were tes-
ted using Affymetrix HG-U133 set microarrays (Affymetrix,
Inc., Santa Clara, CA), as described previously [2].
Bioinformatics Data Analysis
Bioinformatics analysis was performed as previously
reported [20]. Statistical algorithm, implanted in Affymetrix
Suite Version 5.0 software (MAS5; Affymetrix, Inc.), gener-
ated a signal value (which designates a relative measure of
the abundance of a transcript), a detection P value (which
indicates the reliability of the transcript’s detection call), and
a detection call (present, absent, or marginal) for each
transcript on a microarray. Detection calls were calculated,
based on the detection P value, as follows: probe sets with
P > .06 were designated as absent; probe sets with .06 > P >
.04 were designated as marginal; and probe sets with P < .04
were designated as present. Signal values were normalized
both per gene and per entire microarray by dividing each
signal by the median of the gene and by the median of the
microarray. Normalized data were then subjected to filtering,
leaving 19,097 probe sets of 56,000 probes presented on the
microarray that were present in at least four of eight tested
arrays. Genes that distinguished between the AURKA Phe31
and AURKA Ile31 groups were delineated from 19,097 tran-
scripts, based on two different statistical approaches using
GeneSpring version 7 software (Silicon Genetics, Redwood
City, CA): one-way analysis of variance (ANOVA) with P =
.05 and one-way ANOVA with multiple correction restric-
tion analysis using the Benjamini and Hochberg false dis-
covery rate (FDR) algorithm, with P = .05 as cutoff for
statistical significance.
Genes that differentiated between the two groups of
Phe31- and Ile31-homozygous RNA were subjected to an-
notation analysis. Functional classification in Gene Ontology
(GO) was examined to find annotation categories that are
overrepresented compared to their representation in the
array. Annotation analysis was preformed using ‘‘David’’
and Expression Analysis Systematic Explorer (EASE) soft-
ware application (http://apps1.niaid.nih.gov/david/). Fisher’s
exact test was applied to choose categories that were
significantly overrepresented (P < .05). Statistical P values
were calculated using SPSS software version 12 (SPSS,
Chicago, IL).
Expression of NKTR Transcript Variants in RNA
from Human Tissues
cDNA from commercial normal RNA of brain, placenta,
muscle, skeletal muscle, lung, kidney, colon, adipose, white
blood cells, and prostate were prepared as described above.
RT-PCRs were performed using StartFast Taq Polymerase
(Roche Diagnostics) as described above, using three pairs of
NKTR primers (NKTR Ex1–Int6b, NKTR Ex6–Int6a, and
NKTR Ex6–Ex8a) and GAPDH primers (primer sequences
and reaction conditions are detailed in Table 1A). PCR frag-
ments were separated by 2% agarose gel electrophoresis.
Results
Genotyping Commercial RNA Samples for AURKA Phe31Ile
Sequence Alteration
Two nonsynonymous SNPs have been identified in the
AURKA gene: T91A (Phe31Ile) and G169A (Val57Ile). Ge-
notyping for T91A (Phe31Ile) was supplemented by geno-
typing for G169A (Val57Ile) to rule out the possible influence
of the latter on the overexpression of AURKA.
Of the 28 RNA samples, 3 were Phe31-homozygous
(two were Val57-homozygous and one was Val57/Ile57–
homozygous), 5 were homozygous for both Ile31 and
Val57 alleles, and 20 were Phe31/Ile31–heterozygous (11
were Val57/Val57–heterozygous and 9 were Val57/Ile57–
heterozygous). The small number of homozygous samples is
a recognized limitation; however, all commercial prostate
RNA samples available at the time of the study were pur-
chased, and additional samples were not available. The ages
of the three donors homozygous for the wild-type Phe31
allele were 23, 69, and 71 years. The age range of the five
donors homozygous for the Ile31 allele was 26 to 65 years
(average, 36 years; median, 27 years). The age range of the
20 heterozygous Phe31/Ile31 donors was 20 to 76 years
(average, 32 years; median, 26 years). The lifetime risk for
prostate cancer is 17% to 20%. Given the donor ages, it is of
note that the prostate tissue classified herein as normal
might have eventually undergone malignant change in some
of the donors.
DHPLC analysis performed on eight commercial homo-
zygous RNA samples (three Phe31 samples and five Ile31
samples) displayed DHPLC patterns identical to chromato-
gram patterns obtained from individual subclones of each
AURKA variant (data not shown), further confirming their
homozygosity and the homogeneity of these RNA samples.
AURKA Is Overexpressed in Normal Homozygous
and Heterozygous Ile31 Prostate RNA
Expression levels of AURKA in normal prostate tissues
were examined using quantitativeRT-PCRanalysis ofAURKA
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Ex2–Ex5 amplification. In this experiment, RNA samples of
Ile31-homozygous (n = 5), Phe31-homozygous (n = 3),
and Phe31/Ile31–heterozygous (n = 20) genotypes were
compared. AURKA overexpression was demonstrated in
Ile31-homozygous and Phe31/Ile31–heterozygous RNA
samples (2.07-fold and 1.93-fold, respectively) compared to
Phe31-homozygousRNA samples (relative expression values
of 1.30 ± 0.27, 1.21 ± 0.37, and 0.63 ± 0.10, respectively; P <
.05; Figure 1). No significant difference was found between the
Ile31/Ile31 and Phe31/Ile31 genotype groups.
AURKA Is Overexpressed in Human Prostate Cancer
Xenografts Homozygous for Both AURKA Ile31
and Phe31 Alleles
The WISH-PC14 xenograft, which was found to be homo-
zygous for the AURKA Ile31 allele, demonstrated significant
overexpression (8.5-fold) of AURKA compared to RNA from
normal AURKA Phe31-homozygous prostates. The WM2.C
and LuCaP35 xenografts, both homozygous for the Phe31
allele, also overexpressed AURKA (9.3-fold and 5.2-fold,
respectively) compared to RNA from normal AURKA
Phe31-homozygous prostates (data not shown).
Identification of Genes That May Be Associated
with AURKA Ile31 Overexpression
To identify novel genes and genetic pathways associated
with the Ile31 allele, we used the Affymetrix HG-U133 set
microarrays to compare global gene expression in normal
prostates homozygous for the Phe31 (n = 3) and Ile31 (n = 5)
alleles. Of the 56,000 probes presented on the microarray,
the 19,097 transcripts passed the first filtration present in
at least four of eight experimental arrays. We then applied
one-way ANOVA for each of the genes separately. Genes
totaling 1509 were distinguished between the two different
genotype groups (homozygous for either AURKA Phe31 or
AURKA Ile31), whereas only 955 genes were expected to
pass this test by chance alone. This analysis provided an
estimation of how distinct these two groups of prostate
tissues are.
A Novel Splice Variant of the NKTR Gene Is Overexpressed
in Normal Homozygous AURKA Ile31 Prostate RNA
One-way ANOVA, followed by multiple correction re-
striction analysis using the Benjamini and Hochberg FDR
algorithm, detected a single transcript, the NKTR overex-
pressed in normal prostate tissue homozygous for AURKA
Ile31 compared to normal prostate tissue homozygous for
AURKA Phe31 (Figure 2A). Interestingly, the overexpressed
Affymetrix probe set for the NKTR transcript hybridized to
sequences in intron 6 of the NKTR gene. Amplification of
the NKTR region spanning from a primer at exon 6 to a
primer at intron 6 (primers Ex6F and Int6aR; Table 1A)
revealed a 138-bp cDNA fragment, including 64 bp of intron
6, with a unique open reading frame (ORF; Figure 3A). The
full ORF fragment of this transcript was identified in a
spectrum of human tissues using specific primers located
at exon 1 (Ex1F) and intron 6 (Int6bR), upstream of the
NKTR ATG codon and downstream of the putative stop
codon of this novel NKTR transcript, respectively (658 bp;
Figure 3A), with greater abundance in brain, lung, adipose,
and prostate RNA. This alternative splice variant includes a
(5V) 28-bp sequence from intron 6 that has been previously
reported in an alternative NKTR transcript that includes
only the 28 bp of intron 6 [21] (Figure 3B). The newly
described and previously published splice variants share
the same 5V splice site in intron 6. The full putative ORF of
this novel splice transcript is presented in Figure 3C. It is
worth noting that the transcript containing the 28 bp of intron
6 alone, which was also presented as a probe set on the
Affymetrix microarray, was not overexpressed.
Quantitative RT-PCR, using primer pairs Ex6F and Int6aR
(Table 1B) to amplify the 138-bp fragment, confirmed a 2.6
overexpression of this specific NKTR splice variant in RNA
samples homozygous for the Ile31 allele compared to sam-
ples homozygous for Phe31 (n = 5 and n = 3, 1.46 ± 0.31 and
0.57 ± 0.58, respectively; t-test, P < .05; Figure 2B).
A Potentially Pro-Oncogenic Expression Pattern Was
Detected in Normal Homozygous AURKA Ile31
Prostate RNA
The classification of genes based on GO terms is a power-
ful bioinformatics tool for expression microarray analysis,
and GO overrepresentation analysis allows the identification
of families of genes that may play significant molecular and
biologic roles. EASE software [22,23] was used to annotate
the 1509 genes differentially expressed in prostate RNA sam-
ples homozygous for either the AURKA Ile31 or the AURKA
Phe31 variant. Of the 1509 genes identified by ANOVA, the
GO database provided annotation for 644 (42.7%) genes of
biologic processes (Figure W1), 679 (45.0%) genes of molec-
ular processes, and 572 (37.9%) genes of cellular processes.
These annotations revealed statistically significant gene ex-
pression variations in multiple categories. In the cellular pro-
cess genes category, overall changes in the metabolism of
DNA, RNA, and proteins were demonstrated. Statistically
Figure 1. Quantitative RT-PCR analysis of the AURKA gene in normal
prostate RNA samples homozygous for AURKA Phe31, heterozygous for
Phe31/Ile31, and homozygous for Ile31 alleles. Values represent mRNA ex-
pression levels that were obtained from 10 ng of total RNA divided by NPC1
mRNA values (cDNA obtained from 1 g of total RNA). Relative expression
units were calculated by a standard curve using LightCycler 5.1 software
(Roche Applied Bioscience). n, number of RNA samples tested.
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significant differences were observed in ribosomal subunits,
splicosomes, ribonuclear-related and translation initiation com-
plexes, as well as in nucleoplasm categories (data not shown).
Information regarding genes reported in Figure W1 is pre-
sented in Table W2 (http://apps1.niaid.nih.gov/david/).
Overrepresented categories of biologic processes included
cell cycle arrest, ubiquitin cycle, antiapoptosis, angiogenesis,
establishment and/or maintenance of chromatin architecture,
and cell migration (Figure W1). Figure 4 presents two of these
annotation categories with the expression levels of all genes
in each category in both the homozygous AURKA Phe31
group and the homozygous Ile31 group. For each gene in
these categories, the ratio of the expression level in prostate
RNA samples homozygous for AURKA Ile31 to the expres-
sion level in prostate RNA samples homozygous for AURKA
Phe31 was determined. In the cell cycle arrest category, we
detected six genes (CDKN1C, CDKN1B, PCAF, ZAK,
SENSN2, and C10orf7 ) that were significantly downregu-
lated and one gene (PLAGL1) that was significantly upregu-
lated in AURKA Ile31 samples compared to AURKA Phe31
samples (Figure 4A).
Given the role of CDKN1C, also termed p57, as a potent
inhibitor of several G1 cyclin/cyclin–dependent kinase com-
plexes and as a negative regulator of cell proliferation
[24,25], this gene was chosen for validation by quantitative
RNA expression analysis. Quantitative RT-PCR confirmed a
13.5-fold downregulation of CDKN1C in Ile31 homozygote
versus Phe31 homozygote RNA samples derived from nor-
mal prostates (n = 5 and n = 2, 1 ± 0.7 and 13.5 ± 0.7,
respectively; t-test, P < .05).
The expression changes seen in genes included in the
antiapoptosis annotation category are demonstrated in
Figure 4B. Four genes were downregulated in AURKA
Ile31 tissues compared to normal prostate tissues homozy-
gous for AURKA Phe31, and changes in three of them (BAX,
BNIP3L, and TNFAIP3) were statistically significant. Simi-
larly, the expression of five genes was upregulated in the
group of homozygous Ile31 RNA samples. Changes in three
genes (NOTCH2, BIRC6, and MALT1) were statistically
significant, suggesting that alterations in apoptosis may take
place in normal prostates homozygous for the AURKA Ile31
allele. The proapoptotic BAX gene [26] was chosen for
quantitative RT-PCR validation, which confirmed the 1.8-fold
downregulation of this gene in homozygous Ile31 samples,
compared to homozygous Phe31 prostate RNA samples
(n = 5 and n = 3, 1.3 ± 0.36 and 2.4 ± 0.9, respectively;
t-test, P = .057).
Discussion
Centrosome defects and deregulation of mitotic apparatus,
chromosomal instability, and aneuploidy have been implicated
in the pathway of events leading to prostate cancer [27], sug-
gesting a link between regulators of mitosis and tumor initia-
tion. The overexpression of the mitosis-regulating AURKA
demonstrated in prostate tumors in human andmousemodels
[2,8,28], together with the demonstration of elevated AURKA
expression in high-grade prostatic intraepithelial neoplasia
(PIN) and, to a lesser degree, in normal cells in cancer-
containing prostates, suggests that AURKA overexpression
may play an early role in prostate tumorigenesis [6]. Func-
tional analyses have implicated the AURKA SNP, T91A
(Phe31Ile), in malignant transformation, and substantial
epidemiological evidence supports the AURKA 91A variant
as a low-penetrance cancer-susceptibility allele [14,16]. In the
present study, we investigated the biologic consequences of
the AURKA Ile31 allelic variant and changes in overall gene
expression profile in human prostate.
Quantitative RT-PCR analysis of RNA from normal pros-
tatic tissue demonstrated that the Ile31/Ile31 and Phe31/
Ile31 AURKA genotypes were associated with significant
AURKA overexpression, although not to the degree detected
in an advanced prostate cancer xenograft [2]. Interestingly,
AURKA, independent of its genotype (Ile31 or Phe31), was
significantly overexpressed in a small number of prostate
tumor xenografts compared to normal prostate tissues. To
Figure 2. Significant overexpression of the novel NKTR transcript in prostate RNA samples homozygous for the AURKA Ile31 compared to prostate RNA samples
homozygous for AURKA Phe31. (A) Affymetrix-normalized expression values of probe set 231235_at following multiple correction restriction analysis using the
Benjamini and Hochberg FDR algorithm (P = .05). (B) Relative expression of the novel NKTR transcript using quantitative RT-PCR with primer pair Ex6F– Int6aR
to generate a 138-bp fragment from NKTR exon 6 to intron 6. Values represent mRNA levels of expression that were obtained from 10 ng of total RNA divided by
the values of the expression levels of the NPC1 gene (P < .005). Relative expression units were calculated by standard curves using LightCycler 5.1 software
(Roche Applied Bioscience). Pr, prostate RNA sample number.
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our knowledge, this is the first demonstration of Ile31-related
overexpression of AURKA in normal prostate tissue.
Despite substantial evidence supporting an association
between enhanced AURKA expression and genetic insta-
bility, induced overexpression of AURKA in primary mouse
embryonic fibroblasts did not promote colony formation [29],
suggesting that additional alterations (mutations and alter-
ations in expression) cooperate with AURKA overexpression
to induce tumorigenesis. To identify genes that may be
related to the AURKA Ile31/Ile31 genotype, global prostate
RNA expression profiles from homozygous Phe31 (n = 3)
and Ile31 (n = 5) samples were analyzed using Affymetrix
microarray. Genes whose expression levels differentiated
between these two genotypes were categorized by GO,
which revealed gene families implicated in processes under-
lying carcinogenesis, such as cell cycle arrest, ubiquitin
cycle, antiapoptosis, angiogenesis, establishment and/or
maintenance of chromatin architecture, and cell migration.
Disruption of the normal cell cycle is a critical step in
cancer development. Because the major regulatory events
leading to cell proliferation and differentiation occur within the
G1 phase of the cell cycle, attention has been focused on
altered expression patterns of G1 cyclins, cyclin-dependent
kinases, and the Cip/Kip family of cyclin-dependent kinase
inhibitors, including CDKN1C [30]. Decreased CDKN1C
expression has been associated with pancreatic [31], hepa-
tocelluar [32], ovarian [33], and bladder [34] carcinomas, and
the tumor-suppressive activities of this inhibitor of cell cycle
progression have been established in experimental models
[35,36]. Interestingly, we demonstrated significantly de-
creased CDKN1C expression in AURKA Ile31/Ile31 normal
prostates. Additionally, we demonstrated downregulation of
the proapoptotic BAX gene in RNA from AURKA Ile31/Ile31
normal prostates. Because dysfunctional apoptotic pro-
gramming and suppression of apoptosis have also been im-
plicated in prostate cancer development and progression
[30], our data further suggest that the AURKA Ile31/Ile31
genotype influences a network of interacting genes and path-
ways, possibly inducing an imbalance in signals promoting
and inhibiting cellular proliferation and apoptosis, respectively;
compromising the fidelity of cell cycle progression; and setting
the stage for potential proliferation and tumorigenesis.
Figure 4. Comparison of normalized gene expression values that are differentially expressed in normal prostates homozygous for either AURKA Phe31 or Ile31.
The expression values of two molecular annotations are presented: cell cycle arrest (A) and antiapoptosis (B). Values on the two left bars represent the average of
normalized mRNA expression obtained from each group homozygous for the AURKA Ile31 allele (n = 5; middle bar) and for the Phe31 allele (n = 3; left bar). The
ratio between groups (right bar) was calculated as the mean in AURKA Ile31 samples divided by the mean in AURKA Phe31 samples. *Genes whose expression
levels were significantly changed between the two AURKA genotype groups of normal prostate RNA samples (t-test, P < .05).
Figure 3. Expression analysis and gene structure of the novel NKTR transcript that is overexpressed in normal homozygous AURKA Ile31 prostates. (A)
Expression of the NKTR transcript in a variety of human tissues. RT-PCR amplification of the 658-bp full ORF transcript spanning from exon 1 (upstream of the
ATG codon) to intron 6 (downstream of the putative stop codon; upper panel). The expression pattern of the 138-bp-short fragment spanning from exon 6 to intron
6, which is presented on the microarray (middle panel) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene (lower panel), is also demonstrated. RT-
PCR was performed using human commercial whole brain RNA (lane 1 from left), placenta (lane 2), muscle (lane 3), skeletal muscle (lane 4), lung (lane 5), kidney
(lane 6), colon (lane 7), adipose (lane 8), white blood cells (lane 9), and prostate (lane 10). RT-PCR without cDNA was used as a negative control (lane 11). Lane 12
contains a 100-bp ladder. (B) The structure of the NKTR gene (upper row, according to Ensembl gene report for ENSG00000114857) and the two alternative splice
variants that contain sequences from intron 6. The novel alternative splice site variant (lower row) shares the (5 V) 28-bp sequence of intron 6 with the transcript
previously reported by Rinfret and Anderson [21], which contains only the 28 bp of intron 6 (middle row). The coding sequence in intron 6 of both alternative splice
variants start at the same 5 V base. Lines and boxes represent introns and exons, respectively. Full box, coding sequences; empty box, noncoding sequences; ex,
exon; int, intron. (C) Sequence of the novel splice site NKTR variant, including an ORF of 193 amino acids. The ATG and putative stop codon are in boldface.
Intronic sequences are in lower case. The first 28 bp that originated from intron 6, identical to those previously published [21], are underlined.
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We consider the results of the hypothesis-generating
microarray experiment due to the availability of only a small
number of homozygous samples. However, when using strin-
gent statistical criteria (FDR), we identified a specific tran-
script, the NKTR variant, that differentiated between AURKA
Phe31/Phe31 and Ile31/Ile31 prostate RNA. Although the
identification of only one discriminating transcript may be
the result of the small number of samples, it emphasizes the
significance of NKTR transcript overexpression in AURKA
Ile31 homozygotes. The NKTR gene, mapped to human
chromosome 3p23–p21 [37], encodes for the NKTR, a
150,000-Da protein, with a unique amino acid structure
consisting of a 58-amino-acid hydrophobic amino terminus
followed by a cyclophilin-related domain [38,39]. NKTRs are
principally expressed and functional on the surface of natural
killer (NK) cells, a subpopulation of white blood cells (large
granular lymphocytes) that are essential effectors of anti-
tumor immune responses in vivo [38,40–42]. NKTR plays a
central role in NK-mediated tumor recognition and lysis [43].
Detection of the overexpression of this novel NKTR variant
in normal AURKA Ile31/Ile31 prostates imposes a number
of interesting questions. Possibly, concomitant expression
of an NK protein both in NK effector cells and in Ile31-
homozygous prostate cells, which are potential premalignant
candidate targets of NK-mediated tumor recognition and
lysis, might enable these target cells to escape recognition
and NK-mediated cytotoxicity. A similar example has been
recently reported in a melanoma model in relation to CD66a
expression by both NK cells and melanoma cells in humans
[44]. The interaction between these cells, through the homo-
typic protein, was demonstrated to result in NK cell inhibition,
thus providing a possibly novel mechanism of major histo-
compatibility complex–independent inhibitory mechanism of
cytotoxicity. Chromosome 3p deletion has been commonly
demonstrated in human cancers, including prostate cancer
[45–47]. Nevertheless, our preliminary analysis of NKTR
expression levels in three prostate xenografts does not
reveal significant NKTR overexpression, nor does it suggest
3p deletion (data not shown).
In summary, we report the first demonstration of AURKA
gene overexpression related to the AURKA Ile31 variant in
normal prostates homozygous or heterozygous for this ge-
netic change. The identification of altered gene expression
profiles in Ile31-homozygote prostates, including genes re-
lated to mechanisms of carcinogenesis, suggests that the
AURKA Ile31 variant may be involved in the disruption of
normal prostate transcriptome and may increase the risk for
prostate tumorigenesis. Overexpression of the novel NKTR
splice variant revealed in AURKA Ile31 carriers should be
further studied to explore the relationship between NKTR
and AURKA expression.
Acknowledgements
We thank Dani Bercovich for his expert assistance with
DHPLC. We thank Merav Kedmi and Nicola Mabjeesh for
their advice and support.
References
[1] Schaid DJ (2004). The complex genetic epidemiology of prostate can-
cer. Hum Mol Genet 13, R103–R121.
[2] Bar-Shira A, Pinthus JH, Rozovsky U, Goldstein M, Sellers WR, Yaron
Y, Eshhar Z, and Orr-Urtreger A (2002). Multiple genes in human 20q13
chromosomal region are involved in an advanced prostate cancer xeno-
graft. Cancer Res 62, 6803–6807.
[3] Marumoto T, Zhang D, and Saya H (2005). Aurora-A—a guardian of
poles. Nat Rev Cancer 5, 42–50.
[4] Goldstein M, Meller I, Issakov J, and Orr-Urtreger A (2006). Novel genes
implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma:
a cytogenetic and molecular analysis of primary tumors. Neoplasia 8,
332–343.
[5] Hoque A, Carter J, Xia W, Hung MC, Sahin AA, Sen S, and Lippman SM
(2003). Loss of aurora A/STK15/BTAK overexpression correlates with
transition of in situ to invasive ductal carcinoma of the breast. Cancer
Epidemiol Biomark Prev 12, 1518–1522.
[6] Buschhorn HM, Klein RR, Chambers SM, Hardy MC, Green S, Bearss
D, and Nagle RB (2005). Aurora-A over-expression in high-grade PIN
lesions and prostate cancer. Prostate 64, 341–346.
[7] Sen S, Zhou H, and White RA (1997). A putative serine/threonine ki-
nase encoding gene BTAK on chromosome 20q13 is amplified and
overexpressed in human breast cancer cell lines. Oncogene 14,
2195–2200.
[8] Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B,
Flanagan P, Clairvoyant F, Ginther C, et al. (1998). A homologue of
Drosophila aurora kinase is oncogenic and amplified in human colo-
rectal cancers. EMBO J 17, 3052–3065.
[9] Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR,
and Sen S (1998). Tumour amplified kinase STK15/BTAK induces cen-
trosome amplification, aneuploidy and transformation. Nat Genet 20,
189–193.
[10] Miao X, Sun T, Wang Y, Zhang X, Tan W, and Lin D (2004). Functional
STK15 Phe31Ile polymorphism is associated with the occurrence and
advanced disease status of esophageal squamous cell carcinoma. Can-
cer Res 64, 2680–2683.
[11] Sun T, Miao X, Wang J, Tan W, Zhou Y, Yu C, and Lin D (2004). Func-
tional Phe31Ile polymorphism in Aurora A and risk of breast carcinoma.
Carcinogenesis 25, 2225–2230.
[12] Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H, McGuire V,
Hogdall E, Shah MN, Luben RN, Easton DF, et al. (2004). STK15 poly-
morphisms and association with risk of invasive ovarian cancer. Cancer
Epidemiol Biomark Prev 13, 1589–1594.
[13] Gu J, Gong Y, Huang M, Lu C, Spitz MR, and Wu X (2007). Polymor-
phisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians.
Carcinogenesis 28, 350–355.
[14] Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J, Chan F,
MacCarthy-Morrogh L, Ponder BA, Nagase H, Burn J, et al. (2003).
Identification of Stk6/STK15 as a candidate low-penetrance tumor-
susceptibility gene in mouse and human. Nat Genet 34, 403–412.
[15] Cox DG, Hankinson SE, and Hunter DJ (2006). Polymorphisms of the
AURKA (STK15/Aurora kinase) gene and breast cancer risk (United
States). Cancer Causes Control 17, 81–83.
[16] Ewart-Toland A, Dai Q, Gao YT, Nagase H, Dunlop MG, Farrington SM,
Barnetson RA, Anton-Culver H, Peel D, Ziogas A, et al. (2005). Aurora-
A/STK15 T + 91A is a general low penetrance cancer susceptibility
gene: a meta-analysis of multiple cancer types. Carcinogenesis 26,
1368–1373.
[17] Hienonen T, Salovaara R, Mecklin JP, Jarvinen H, Karhu A, and Aaltonen
LA (2006). Preferential amplification ofAURKA 91A (Ile31) in familial colo-
rectal cancers. Int J Cancer 118, 505–508.
[18] Corey E, Quinn JE, Buhler KR, Nelson PS, Macoska JA, True LD, and
Vessella RL (2003). LuCaP 35: a new model of prostate cancer pro-
gression to androgen independence. Prostate 55, 239–246.
[19] Orr-Urtreger A, Bar-Shira A, Bercovich D, Matarasso N, Rozovsky U,
Rosner S, Soloviov S, Rennert G, Kadouri L, Hubert A, et al. (2006).
RNASEL mutation screening and association study in Ashkenazi and
non-Ashkenazi prostate cancer patients. Cancer Epidemiol Biomark
Prev 15, 474–479.
[20] Kedmi M and Orr-Urtreger A (2007). Differential brain transcriptome of
beta4 nAChR subunit –deficient mice: is it the effect of the null mutation
or the background strain? Physiol Genomics 28, 213–222.
[21] Rinfret A and Anderson SK (1993). IL-2 regulates the expression of the
NK-TR gene via an alternate RNA splicing mechanism. Mol Immunol
30, 1307–1313.
[22] Dennis C (2003). Draft guidelines ease restrictions on use of genome
sequence data. Nature 421, 877–878.
714 Overexpression of AURKA in AURKA Ile31 in Human Prostate Matarasso et al.
[23] Hosack DA, Dennis G Jr, Sherman BT, Lane HC, and Lempicki RA
(2003). Identifying biological themes within lists of genes with EASE.
Genome Biol 4, R70.
[24] Lee MH, Reynisdottir I, and Massague J (1995). Cloning of p57KIP2, a
cyclin-dependent kinase inhibitor with unique domain structure and tis-
sue distribution. Genes Dev 9, 639–649.
[25] Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper
JW, and Elledge SJ (1995). p57KIP2, a structurally distinct member of
the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
Genes Dev 9, 650–662.
[26] Oltvai ZN, Milliman CL, and Korsmeyer SJ (1993). Bcl-2 heterodimerizes
in vivo with a conserved homolog, Bax, that accelerates programmed cell
death. Cell 74, 609–619.
[27] Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L, and Doxsey SJ
(2001). Centrosome defects can account for cellular and genetic
changes that characterize prostate cancer progression. Cancer Res
61, 2212–2219.
[28] Lee EC, Frolov A, Li R, Ayala G, and Greenberg NM (2006). Targeting
Aurora kinases for the treatment of prostate cancer. Cancer Res 66,
4996–5002.
[29] Anand S, Penrhyn-Lowe S, and Venkitaraman AR (2003). AURORA-A
amplification overrides the mitotic spindle assembly checkpoint, induc-
ing resistance to Taxol. Cancer Cell 3, 51–62.
[30] Bruckheimer EM and Kyprianou N (2000). Apoptosis in prostate carci-
nogenesis. A growth regulator and a therapeutic target. Cell Tissue Res
301, 153–162.
[31] Sato N, Matsubayashi H, Abe T, Fukushima N, and Goggins M (2005).
Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal
neoplasms identified by gene expression profiling. Clin Cancer Res 11,
4681–4688.
[32] Ito Y, Takeda T, Sakon M, Tsujimoto M, Monden M, and Matsuura N
(2001). Expression of p57/Kip2 protein in hepatocellular carcinoma.
Oncology 61, 221–225.
[33] Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, and Tokuda M
(2002). Expression of p57kip2 and its clinical relevance in epithelial
ovarian tumors. Anticancer Res 22, 3191–3196.
[34] Oya M and Schulz WA (2000). Decreased expression of p57(KIP2)
mRNA in human bladder cancer. Br J Cancer 83, 626–631.
[35] Watanabe H, Pan ZQ, Schreiber-Agus N, DePinho RA, Hurwitz J, and
Xiong Y (1998). Suppression of cell transformation by the cyclin-
dependent kinase inhibitor p57KIP2 requires binding to proliferating cell
nuclear antigen. Proc Natl Acad Sci USA 95, 1392–1397.
[36] Tsugu A, Sakai K, Dirks PB, Jung S, Weksberg R, Fei YL, Mondal S,
Ivanchuk S, Ackerley C, Hamel PA, et al. (2000). Expression of
p57(KIP2) potently blocks the growth of human astrocytomas and in-
duces cell senescence. Am J Pathol 157, 919–932.
[37] Young HA, Jenkins NA, Copeland NG, Simek S, Lerman MI, Zbar B,
Glenn G, Ortaldo JR, and Anderson SK (1993). Localization of a novel
natural killer triggering receptor locus to human chromosome 3p23–
p21 and mouse chromosome 9. Genomics 16, 548–549.
[38] Frey JL, Bino T, Kantor RR, Segal DM, Giardina SL, Roder J, Anderson
S, and Ortaldo JR (1991). Mechanism of target cell recognition by
natural killer cells: characterization of a novel triggering molecule re-
stricted to CD3 large granular lymphocytes. J Exp Med 174,
1527–1536.
[39] Anderson SK, Gallinger S, Roder J, Frey J, Young HA, and Ortaldo JR
(1993). A cyclophilin-related protein involved in the function of natural
killer cells. Proc Natl Acad Sci USA 90, 542–546.
[40] Trinchieri G (1989). Biology of natural killer cells. Adv Immunol 47,
187–376.
[41] Kim S, Iizuka K, Aguila HL, Weissman IL, and Yokoyama WM (2000).
In vivo natural killer cell activities revealed by natural killer cell – deficient
mice. Proc Natl Acad Sci USA 97, 2731–2736.
[42] Mocellin S, Rossi CR, and Nitti D (2004). Cancer vaccine development:
on the way to break immune tolerance to malignant cells. Exp Cell Res
299, 267–278.
[43] Giardina SL, Anderson SK, Sayers TJ, Chambers WH, Palumbo GA,
Young HA, and Ortaldo JR (1995). Selective loss of NK cytotoxicity in
antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent
tumor and virus-infected target cell killing. J Immunol 154, 80–87.
[44] Markel G, Lieberman N, Katz G, Arnon TI, Lotem M, Drize O, Blumberg
RS, Bar-Haim E, Mader R, Eisenbach L, et al. (2002). CD66a interac-
tions between human melanoma and NK cells: a novel class I MHC-
independent inhibitory mechanism of cytotoxicity. J Immunol 168,
2803–2810.
[45] Hesson LB, Cooper WN, and Latif F (2007). Evaluation of the 3p21.3
tumour-suppressor gene cluster. Oncogene (advance online publica-
tion, May 28, 2007).
[46] BashyamMD, Bair R, Kim YH, Wang P, Hernandez-Boussard T, Karikari
CA, Tibshirani R, Maitra A, and Pollack JR (2005). Array-based com-
parative genomic hybridization identifies localized DNA amplifica-
tions and homozygous deletions in pancreatic cancer. Neoplasia 7,
556–562.
[47] Wolf M, Mousses S, Hautaniemi S, Karhu R, Huusko P, Allinen M,
Elkahloun A, Monni O, Chen Y, Kallioniemi A, et al. (2004). High-
resolution analysis of gene copy number alterations in human prostate
cancer using CGH on cDNA microarrays: impact of copy number on
gene expression. Neoplasia 6, 240–247.
Overexpression of AURKA in AURKA Ile31 in Human Prostate Matarasso et al. 715
Table W1. Ages of the Donors.
Sample AURKA Genotype Age (years)
Pr3 Phe31/Phe31 23
Pr19 Phe31/Phe31 69
PA2 Phe31/Phe31 71
Pr7 Ile31/Ile31 27
Pr8 Ile31/Ile31 36
Pr9 Ile31/Ile31 27
Pr12 Ile31/Ile31 65
Pr20 Ile31/Ile31 26
Pr1 Phe31/Ile31 26
Pr2 Phe31/Ile31 41
Pr4 Phe31/Ile31 24
Pr5 Phe31/Ile31 27
Pr6 Phe31/Ile31 29
Pr10 Phe31/Ile31 25
Pr11 Phe31/Ile31 34
Pr13 Phe31/Ile31 20
Pr14 Phe31/Ile31 29
Pr15 Phe31/Ile31 29
Pr16 Phe31/Ile31 26
Pr17 Phe31/Ile31 76
Pr18 Phe31/Ile31 66
Pr21 Phe31/Ile31 27
Pr23 Phe31/Ile31 27
Pr24 Phe31/Ile31 21
Pr25 Phe31/Ile31 20
Pr26 Phe31/Ile31 24
Pr28 Phe31/Ile31 26
Pr29 Phe31/Ile31 24
Figure W1. Functional annotation analysis of genes in the ‘‘biologic process’’ annotation category that significantly differentiates between normal prostates
homozygous for either the AURKA Phe31 allele or the AURKA Ile31 allele. GO annotation analysis was performed using EASE software. Ontologies are presented
as hierarchical trees. Categories with brackets are significantly overrepresented (Fisher’s exact test, P < .05) with a threshold of at least two genes in the category.
The first number (in brackets) indicates the number of genes that belong to a certain annotation category among significantly changed genes; the second number
represents the percentage of significantly changed genes in the annotation category; the third number represents the percentage of all genes in the annotation
category among the genes present in the Affymetrix array; and the fourth number represents the calculated P value.
Table W2. Genes Identified By GO Annotation.
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
Cell cycle arrest
201725_at 8872 Chromosome 10, open reading
frame 7
Biologic process Cell cycle arrest; positive regulation of cell proliferation
202443_x_at 4853 Notch homolog 2 (Drosophila) Biologic process Notch signaling pathway; antiapoptosis; calcium
ion binding; cell cycle arrest; cell differentiation;
cell fate determination; cell growth; cell surface;
determination of left/right symmetry; hemopoiesis;
induction of apoptosis; integral to plasma membrane;
ligand-regulated transcription factor activity;
morphogenesis of epithelial sheet; negative
regulation of cell proliferation; neurogenesis;
nucleus; positive regulation of RAS protein
signal transduction; protein binding; protein
heterodimerization activity; receptor activity;
regulation of development; regulation of
transcription, DNA-dependent; stem cell
maintenance; transcription regulator activity
203845_at 8850 p300/CBP–associated factor Biologic process N-Acetyltransferase activity; cell cycle; cell cycle
arrest; chromatin remodeling; histone deacetylase
activity; negative regulation of cell proliferation;
nucleus; protein amino acid acetylation; regulation
of transcription, DNA-dependent; transcription
cofactor activity; transferase activity
209112_at 1027 Cyclin-dependent kinase inhibitor 1B
(p27, Kip1)
Biologic process Cell cycle arrest; cyclin-dependent protein kinase
inhibitor activity; negative regulation of cell
proliferation; nucleus; regulation of CDK activity;
transforming growth factor-b receptor, cytoplasmic
mediator activity
209318_x_at 5325 Pleiomorphic adenoma gene– like 1 Biologic process Cell cycle arrest; induction of apoptosis; induction
of apoptosis by p53; transcription-activating factor;
tumor suppressor
213183_s_at 1028 Cyclin-dependent kinase inhibitor 1C
(p57, Kip2)
Biologic process G1 phase of mitotic cell cycle; cell cycle; cell cycle
arrest; cyclin-dependent protein kinase inhibitor
activity; negative regulation of cell cycle; negative
regulation of cell proliferation; nucleus; regulation
of CDK activity
218346_s_at 27244 Sestrin 1 Biologic process Cell cycle arrest; negative regulation of cell
proliferation; nucleus; response to DNA damage
stimulus
219534_x_at 1028 Cyclin-dependent kinase inhibitor 1C
(p57, Kip2)
Biologic process G1 phase of mitotic cell cycle; cell cycle; cell cycle
arrest; cyclin-dependent protein kinase inhibitor
activity; negative regulation of cell cycle; negative
regulation of cell proliferation; nucleus; regulation
of CDK activity
222757_s_at 51776 Sterile a motif and leucine
zipper–containing kinase AZK
Biologic process ATP binding; DNA damage response; signal
transduction resulting in cell cycle arrest; MAP
kinase kinase kinase activity; activation of
JUNK; activation of MAP/ERK kinase kinase;
activation of MAPKK; cell cycle arrest; cell
death; cell differentiation; cell proliferation;
cellular component unknown; protein amino acid
phosphorylation; protein serine/threonine kinase
activity; protein-tyrosine kinase activity; response
to radiation; response to stress; transferase activity
239585_at 8850 p300/CBP–associated factor Biologic process N-Acetyltransferase activity; cell cycle; cell cycle
arrest; chromatin remodeling; histone deacetylase
activity; negative regulation of cell proliferation;
nucleus; protein amino acid acetylation; regulation
of transcription, DNA-dependent; transcription
cofactor activity; transferase activity
Record count = 10
Ubiquitin cycle
200669_s_at 7323 Ubiquitin-conjugating enzyme E2D 3
(UBC4/5 homolog, yeast)
Biologic process Ligase activity; ubiquitin-conjugating enzyme
activity; ubiquitin cycle; ubiquitin-dependent protein
catabolism; ubiquitin-protein ligase activity
200676_s_at 7332 Ubiquitin-conjugating enzyme E2L 3 Biologic process Enzyme binding; ligase activity; ubiquitin-conjugating
enzyme activity; ubiquitin cycle; ubiquitin ligase
complex; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
201344_at 7322 Ubiquitin-conjugating enzyme E2D 2
(UBC4/5 homolog, yeast)
Biologic process Ligase activity; ubiquitin-conjugating enzyme activity;
ubiquitin cycle; ubiquitin-dependent protein
catabolism; ubiquitin-protein ligase activity
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
201546_at 9320 Thyroid hormone receptor
interactor 12
Biologic process Cellular component unknown; cytosol; intracellular;
ligase activity; protein ubiquitination; thyroid
hormone receptor binding; ubiquitin-protein
ligase activity
201899_s_at 7319 Ubiquitin-conjugating enzyme E2A
(RAD6 homolog)
Biologic process Ligase activity; nucleus; postreplication repair;
ubiquitin-conjugating enzyme activity; ubiquitin
cycle; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
202334_s_at 7320 Ubiquitin-conjugating enzyme E2B
(RAD6 homolog)
Biologic process Ligase activity; nucleus; postreplication repair;
ubiquitin-conjugating enzyme activity; ubiquitin
cycle; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
209475_at 9958 Ubiquitin-specific protease 15 Biologic process Cysteine-type endopeptidase activity; hydrolase
activity; peptidase activity; ubiquitin cycle; ubiquitin
thiolesterase activity; ubiquitin-dependent protein
catabolism; ubiquitin-specific protease activity
210024_s_at 10477 Ubiquitin-conjugating enzyme E2E 3
(UBC4/5 homolog, yeast)
Biologic process Ligase activity; ubiquitin-conjugating enzyme activity;
ubiquitin cycle; ubiquitin-protein ligase activity
213535_s_at 7329 Ubiquitin-conjugating enzyme E2I
(UBC9 homolog, yeast)
Biologic process Ligase activity; synaptonemal complex;
ubiquitin-conjugating enzyme activity; ubiquitin
cycle; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
217978_s_at 55585 Ubiquitin-conjugating enzyme E2Q
(putative)
Biologic process Ubiquitin-conjugating enzyme activity; ubiquitin cycle
224635_s_at 57448 Baculoviral IAP repeat –containing 6
(apollon)
Biologic process Antiapoptosis; apoptosis; cellular component
unknown; cysteine protease inhibitor activity;
intracellular; ligase activity; ubiquitin-conjugating
enzyme activity; ubiquitin cycle
225209_s_at 118424 Ubiquitin-conjugating enzyme E2,
J2 (UBC6 homolog, yeast)
Biologic process Ligase activity; ubiquitin-conjugating enzyme activity;
ubiquitin cycle; ubiquitin-protein ligase activity
230411_at 7336 Ubiquitin-conjugating enzyme
E2 variant 2
Biologic process Cell proliferation; ligase activity; protein
polyubiquitination; regulation of DNA repair;
regulation of cell cycle; ubiquitin-conjugating
enzyme activity; ubiquitin cycle; ubiquitin-protein
ligase activity
Record count = 13
Chromatin modification
201483_s_at 6827 Suppressor of Ty 4 homolog 1
(Saccharomyces cerevisiae)
Biologic process Chromatin remodeling; nucleus; regulation of
transcription from Pol II promoter; transcription;
transcription factor activity
202265_at 648 B lymphoma Mo-MLV insertion
region (mouse)
Biologic process Cell growth and/or maintenance; chromatin
modification; nucleus; regulation of transcription,
DNA-dependent; segment specification
203428_s_at 25842 ASF1 anti –silencing function
1 homolog A (S. cerevisiae)
Biologic process Chromatin binding; loss of chromatin silencing;
nucleus
203845_at 8850 p300/CBP–associated factor Biologic process N-Acetyltransferase activity; cell cycle; cell cycle
arrest; chromatin remodeling; histone deacetylase
activity; negative regulation of cell proliferation;
nucleus; protein amino acid acetylation; regulation
of transcription, DNA-dependent; transcription
cofactor activity; transferase activity
212997_s_at 11011 Tousled-like kinase 2 Biologic process ATP binding; cell cycle; chromatin modification;
intracellular signaling cascade; nucleus; protein
amino acid phosphorylation; protein serine/threonine
kinase activity; regulation of chromatin assembly/
disassembly; response to DNA damage stimulus;
transferase activity
213837_at 26013 l(3)mbt– like (Drosophila) Biologic process Chromatin modification; nucleus; regulation of
transcription, DNA-dependent; transcription
factor activity
215373_x_at 57108 PR/SET domain–containing
protein 07
Biologic process Chromatin modification; histone-lysine
N-methyltransferase activity; methyltransferase
activity; nucleus; transferase activity
222413_s_at 58508 Myeloid/lymphoid or mixed-lineage
leukemia 3
Biologic process DNA binding; chromatin modification; histone-lysine
N-methyltransferase activity; methyltransferase
activity; nucleus; regulation of transcription,
DNA-dependent; transferase activity
225181_at 57492 AT-rich interactive domain 1B
(SWI1-like)
Biologic process DNA binding; SWI/SNF complex; biologic
process unknown; cellular component unknown;
chromatin-mediated maintenance of transcription;
intracellular; molecular function unknown; protein
binding; transcription coactivator activity
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
227679_at 79885 Histone deacetylase 11 Biologic process Chromatin modification; cytoplasm; histone
deacetylase activity; histone deacetylase
complex; hydrolase activity; nucleus; regulation
of transcription, DNA-dependent; transcription
factor binding
231764_at 54108 Chromatin accessibility complex 1 Biologic process DNA binding; chromatin accessibility complex;
chromatin remodeling; e DNA polymerase activity;
e DNA polymerase complex; nucleus
239585_at 8850 p300/CBP–associated factor Biologic process N-Acetyltransferase activity; cell cycle; cell
cycle arrest; chromatin remodeling; histone
deacetylase activity; negative regulation of
cell proliferation; nucleus; protein amino
acid acetylation; regulation of transcription,
DNA-dependent; transcription
cofactor activity; transferase activity
Record count = 12
Nuclear organization and biogenesis
201483_s_at 6827 Suppressor of Ty 4 homolog 1
(S. cerevisiae)
Biologic process Chromatin remodeling; nucleus; regulation of
transcription from Pol II promoter; transcription;
transcription factor activity
201518_at 10951 Chromobox homolog 1 (HP1 b
homolog Drosophila)
Biologic process Chromatin; chromatin assembly/disassembly;
chromatin binding; nuclear heterochromatin;
nucleoplasm
202265_at 648 B-lymphoma Mo-MLV insertion
region (mouse)
Biologic process Cell growth and/or maintenance; chromatin
modification; nucleus; regulation of transcription,
DNA-dependent; segment specification
203428_s_at 25842 ASF1 anti –silencing function 1
homolog A (S. cerevisiae)
Biologic process Chromatin binding; loss of chromatin silencing;
nucleus
203449_s_at 7013 Telomeric repeat binding factor
(NIMA-interacting) 1
Biologic process DNA binding; cell cycle; chromosome, telomeric
region; mitosis; nucleus; protein binding;
telomerase-dependent telomere maintenance
203845_at 8850 p300/CBP–associated factor Biologic process N-Acetyltransferase activity; cell cycle; cell cycle
arrest; chromatin remodeling; histone deacetylase
activity; negative regulation of cell proliferation;
nucleus; protein amino acid acetylation; regulation
of transcription, DNA-dependent; transcription
cofactor activity; transferase activity
206254_at 1950 Epidermal growth factor
(b-urogastrone)
Biologic process DNA replication; activation of MAPK; calcium ion
binding; chromosome organization and biogenesis
(sensu Eukarya); epidermal growth factor receptor
activating ligand activity; epidermal growth factor
receptor signaling pathway; extracellular; growth
factor activity; integral to membrane; nucleus;
plasma membrane; positive regulation of cell
proliferation
209069_s_at 3021 H3 histone, family 3B (H3.3B) Biologic process DNA binding; chromosome; chromosome organization
and biogenesis (sensu Eukarya); nucleosome;
nucleosome assembly; nucleus
209085_x_at 5981 Replication factor C
(activator 1) 1; 145 kDa
Biologic process ATP binding; DNA binding; DNA replication
factor C complex; DNA-dependent DNA
replication; enzyme activator activity; nucleotide
binding; nucleus; regulation of transcription,
DNA-dependent; telomerase-dependent telomere
maintenance
209964_s_at 6314 Spinocerebellar ataxia 7
(olivopontocerebellar atrophy
with retinal degeneration)
Biologic process Molecular function unknown; nuclear organization
and biogenesis; nucleus; visual perception
212997_s_at 11011 Tousled-like kinase 2 Biologic process ATP binding; cell cycle; chromatin modification;
intracellular signaling cascade; nucleus; protein
amino acid phosphorylation; protein serine/threonine
kinase activity; regulation of chromatin assembly/
disassembly; response to DNA damage stimulus;
transferase activity
213048_s_at 6418 SET translocation (myeloid
leukemia–associated)
Biologic process DNA binding; DNA replication; cell growth and/or
maintenance; nucleosome assembly; nucleus;
protein phosphatase inhibitor activity
213837_at 26013 l(3)mbt– like (Drosophila) Biologic process Chromatin modification; nucleus; regulation of
transcription, DNA-dependent; transcription
factor activity
215373_x_at 57108 PR/SET domain–containing
protein 07
Biologic process Chromatin modification; histone-lysine
N-methyltransferase activity; methyltransferase
activity; nucleus; transferase activity
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
221820_s_at 84148 MYST histone acetyltransferase 1 Biologic process Chromatin; chromatin assembly/disassembly;
chromatin binding; nucleus; transferase activity
222413_s_at 58508 Myeloid/lymphoid or mixed-lineage
leukemia 3
Biologic process DNA binding; chromatin modification; histone-lysine
N-methyltransferase activity; methyltransferase
activity; nucleus; regulation of transcription,
DNA-dependent; transferase activity
223907_s_at 54984 PIN2-interacting protein 1 Biologic process Cellular component unknown; chromosome, telomeric
region; molecular function unknown; negative
regulation of cell cycle; negative regulation of
cell proliferation; nucleic acid binding; nucleus;
telomerase-dependent telomere maintenance
224591_at 50809 HP1-BP74 Biologic process DNA binding; nucleosome; nucleosome assembly;
nucleus
225181_at 57492 AT-rich interactive domain 1B
(SWI1-like)
Biologic process DNA binding; SWI/SNF complex; biologic process
unknown; cellular component unknown;
chromatin-mediated maintenance of transcription;
intracellular; molecular function unknown; protein
binding; transcription coactivator activity
225951_s_at 1106 Chromodomain helicase
DNA-binding protein 2
Biologic process ATP binding; ATP-dependent DNA helicase activity;
chromatin; chromatin assembly/disassembly; chromatin
binding; chromosome organization and biogenesis
(sensu Eukarya); helicase activity; hydrolase activity;
nucleus; regulation of transcription from Pol II promoter
226840_at 9555 H2A histone family, member Y Biologic process DNA binding; chromosome; chromosome organization
and biogenesis (sensu Eukarya); nucleosome;
nucleosome assembly; nucleus
227679_at 79885 Histone deacetylase 11 Biologic process Chromatin modification; cytoplasm; histone deacetylase
activity; histone deacetylase complex; hydrolase
activity; nucleus; regulation of transcription,
DNA-dependent; transcription factor binding
229593_at 9555 H2A histone family, member Y Biologic process DNA binding; chromosome; chromosome organization
and biogenesis (sensu Eukarya); nucleosome;
nucleosome assembly; nucleus
231764_at 54108 Chromatin accessibility complex 1 Biologic process DNA binding; chromatin accessibility complex;
chromatin remodeling; e DNA polymerase activity;
e DNA polymerase complex; nucleus
239585_at 8850 p300/CBP–associated factor Biologic process N-Acetyltransferase activity; cell cycle; cell cycle
arrest; chromatin remodeling; histone deacetylase
activity; negative regulation of cell proliferation;
nucleus; protein amino acid acetylation; regulation
of transcription, DNA-dependent; transcription
cofactor activity; transferase activity
40189_at 6418 SET translocation (myeloid
leukemia–associated)
Biologic process DNA binding; DNA replication; cell growth and/or
maintenance; nucleosome assembly; nucleus;
protein phosphatase inhibitor activity
Record count = 26
RNA splicing
200020_at 23435 TAR DNA-binding protein Biologic process RNA binding; microtubule binding; mitosis; nuclear
mRNA splicing by spliceosome; nucleus; regulation
of transcription, DNA-dependent; transcription
factor activity; transcription from Pol II promoter
201342_at 6631 Small nuclear ribonucleoprotein
polypeptide C
Biologic process RNA binding; RNA splicing; snRNP U1
202858_at 7307 U2(RNU2) small nuclear RNA
auxiliary factor 1
Biologic process Cajal body; RNA binding; RNA splicing; nuclear mRNA
splicing by spliceosome; pre-mRNA splicing factor
activity; spliceosome complex
202886_s_at 5519 Protein phosphatase 2 (formerly 2A),
regulatory subunit A (PR 65),
b isoform
Biologic process RNA splicing; antigen binding; ceramide metabolism;
cytosol; inactivation of MAPK; induction of apoptosis;
membrane; microtubule cytoskeleton; mitochondrion;
negative regulation of cell growth; negative regulation
of tyrosine phosphorylation of Stat3 protein; nucleus;
protein amino acid dephosphorylation; protein binding;
protein complex assembly; protein heterodimerization
activity; protein phosphatase type 2A activity; protein
phosphatase type 2A complex; protein phosphatase
type 2A regulator activity; regulation of DNA replication;
regulation of Wnt receptor signaling pathway; regulation
of cell adhesion; regulation of cell cycle; regulation of
cell differentiation; regulation of growth; regulation of
transcription; regulation of translation; response to
organic substance; second-messenger–mediated
signaling; soluble fraction
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
202899_s_at 6428 Splicing factor, arginine/serine– rich 3 Biologic process RNA binding; nuclear mRNA splicing by spliceosome;
nucleus
208672_s_at 6428 Splicing factor, arginine/serine– rich 3 Biologic process RNA binding; nuclear mRNA splicing by spliceosome;
nucleus
210172_at 7536 Splicing factor 1 Biologic process DNA binding; RNA binding; RNA polymerase II
transcription factor activity; biologic process
unknown; metal ion binding; nuclear mRNA
splicing by spliceosome; nucleus; regulation
of transcription, DNA-dependent; spliceosome
complex; transcription corepressor activity
211115_x_at 8487 Survival of motor neuron
protein– interacting protein 1
Biologic process Cytoplasm; pre-mRNA splicing factor activity;
spliceosome assembly; spliceosome complex
212030_at 58517 RNA-binding region
(RNP1, RRM) containing 7
Biologic process Cellular component unknown; mRNA binding;
nuclear mRNA splicing by spliceosome
213575_at 29896 Transformer-2 a Biologic process RNA binding; nuclear mRNA splicing by spliceosome;
nucleus; pre-mRNA splicing factor activity
213593_s_at 29896 Transformer-2 a Biologic process RNA binding; nuclear mRNA splicing by spliceosome;
nucleus; pre-mRNA splicing factor activity
213852_at 9939 RNA-binding motif protein 8A Biologic process Biologic process unknown; cytoplasm; mRNA binding;
mRNA nucleus export; nuclear mRNA splicing by
spliceosome; nucleus; transport
214814_at 91746 Splicing factor YT521-B Biologic process Nuclear mRNA splicing by spliceosome; nucleus
221742_at 10658 CUG triplet repeat, RNA-binding
protein 1
Biologic process BRE binding; RNA interference; embryonic development;
germ-cell development; mRNA processing; mRNA
splice site selection; nucleus; pre-mRNA splicing
factor activity; ribonucleoprotein complex; translation
repressor activity; nucleic acid binding
222514_at 64121 Ras-related GTP-binding C Biologic process GDP binding; RNA splicing; apoptosis; cell growth; cell
growth and/or maintenance; cytoplasm; heterotrimeric
G-protein complex; magnesium ion binding; nucleus;
protein binding; protein heterodimerization activity;
small GTPase–mediated signal transduction; small
monomeric GTPase activity; transcription
223016_x_at 9406 Zinc finger protein 265 Biologic process RNA binding; RNA splicing; nucleus; transcription
factor activity
223331_s_at 11218 DEAD (Asp–Glu–Ala–Asp)
box polypeptide 20
Biologic process ATP binding; ATP-dependent RNA helicase activity;
DNA binding; assembly of spliceosomal tri-snRNP;
cytoskeleton; mRNA processing; spliceosome
complex
225593_at 84967 U7 snRNP-specific Sm-like protein
LSM10
Biologic process RNA binding; nuclear mRNA splicing by spliceosome;
nucleus; pre-mRNA splicing factor activity; small
nucleolar ribonucleoprotein complex
226898_s_at 6421 Splicing factor proline/glutamine–
rich (polypyrimidine tract binding
protein–associated)
Biologic process DNA binding; RNA binding; RNA splicing; nuclear
mRNA splicing by spliceosome; nucleus; pre-mRNA
splicing factor activity
227110_at 3183 Heterogeneous nuclear
ribonucleoprotein C (C1/C2)
Biologic process RNA binding; RNA splicing; heterogeneous nuclear
ribonucleoprotein complex
227223_at 9584 RNA-binding region (RNP1, RRM)
containing 2
Biologic process RNA binding; nuclear mRNA splicing by spliceosome;
nucleus; regulation of transcription, DNA-dependent
229303_at 23451 Splicing factor 3b, subunit 1; 155 kDa Biologic process Nuclear mRNA splicing by spliceosome; pre-mRNA
splicing factor activity; spliceosome complex
242146_at 6627 Small nuclear ribonucleoprotein
polypeptide AV
Biologic process RNA binding; RNA splicing; snRNP U2
Record count = 23
Regulation of transcription from Pol II promoter
200047_s_at 7528 YY1 transcription factor Biologic process Antimicrobial humoral response (sensu Vertebrata);
nucleus; protein binding; regulation of transcription
from Pol II promoter; transcription coactivator
activity; transcription corepressor activity;
transcription factor activity; zinc ion binding
200603_at 5573 Protein kinase, cAMP-dependent,
regulatory, type I, a (tissue-specific
extinguisher 1)
Biologic process 3V,5V-cAMP binding; cAMP-dependent protein
kinase complex; cAMP-dependent protein kinase
regulator activity; intracellular signaling cascade;
protein amino acid phosphorylation; regulation of
transcription from Pol II promoter
201160_s_at 8531 Cold shock domain protein A Biologic process DNA binding; RNA polymerase II transcription factor
activity; cytoplasm; double-stranded DNA binding;
negative regulation of transcription from Pol II
promoter; perinuclear space; regulation of
transcription, DNA-dependent; response to cold;
transcription corepressor activity; transcription
factor activity
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
201483_s_at 6827 Suppressor of Ty 4 homolog 1
(S. cerevisiae)
Biologic process Chromatin remodeling; nucleus; regulation of
transcription from Pol II promoter; transcription;
transcription factor activity
201862_s_at 9208 Leucine-rich repeat (in FLII) –
interacting protein 1
Biologic process RNA polymerase II transcription factor activity;
biologic process unknown; cellular component
unknown; cytoskeleton; double-stranded RNA
binding; molecular function unknown; negative
regulation of transcription; nucleus; regulation of
transcription from Pol II promoter; transcriptional
repressor activity
202079_s_at 22906 OGT (O-Glc–NAc transferase) –
interacting protein; 106 kDa
Biologic process O-linked glycosylation; nucleus; protein binding;
protein targeting; regulation of transcription from
Pol II promoter
202226_s_at 1398 v-crk sarcoma virus CT10 oncogene
homolog (avian)
Biologic process SH3/SH2 adaptor protein activity; actin cytoskeleton
organization and biogenesis; cell growth and/or
maintenance; cell motility; cytoplasm; intracellular
signaling cascade; nucleus; regulation of
transcription from Pol II promoter
203319_s_at 7707 Zinc finger protein 148 (pHZ-52) Biologic process DNA binding; DNA-directed RNA polymerase II,
core complex; cellular defense response; negative
regulation of transcription from Pol II promoter;
nucleus; regulation of transcription, DNA-dependent;
specific RNA polymerase II transcription factor
activity; transcriptional activator activity
204057_at 3394 Interferon consensus sequence–
binding protein 1
Biologic process RNA polymerase II transcription factor activity,
enhancer binding; immune response; negative
regulation of transcription from Pol II promoter;
nucleus; regulation of transcription, DNA-dependent
205253_at 5087 pre–B-cell leukemia transcription
factor 1
Biologic process C21 steroid hormone biosynthesis; carbon use by
fixation of carbon dioxide; cell growth and/or
maintenance; embryonic development; nucleus;
protein binding; regulation of transcription,
DNA-dependent; regulation of transcriptional
preinitiation complex formation; ribulose
bisphosphate carboxylase complex; ribulose
bisphosphate carboxylase activity; sex
differentiation; transcription factor activity;
transcription from Pol II promoter
209292_at 3400 Inhibitor of DNA-binding 4, dominant
negative helix – loop–helix protein
Biologic process Nucleus; regulation of transcription from Pol II
promoter; transcription corepressor activity
209357_at 10370 CBP/p300– interacting transactivator,
with Glu/Asp– rich carboxy-terminal
domain 2
Biologic process Nucleus; protein binding; regulation of transcription
from Pol II promoter; transcription factor activity
212857_x_at 10923 Activated RNA polymerase II
transcription cofactor 4
Biologic process Nucleus; regulation of transcription from Pol II
promoter; single-stranded DNA binding;
transcription; transcription coactivator activity;
transcription factor complex
217501_at 9391 WD40 protein Ciao1 Biologic process Nucleus; positive regulation of cell proliferation;
regulation of transcription from Pol II promoter
217707_x_at 6595 SWI/SNF– related, matrix-associated,
actin-dependent regulator of
chromatin, subfamily a, member 2
Biologic process ATP binding; ATP-dependent helicase activity;
DNA binding; nucleoplasm; regulation of
transcription from Pol II promoter; transcription
coactivator activity
222266_at 8725 Chromosome 19, open reading
frame 2
Biologic process DNA-directed RNA polymerase II, core complex;
chaperone activity; cytoplasm; nucleus; prefolding
complex; protein folding; regulation of transcription
from Pol II promoter; response to virus; transcription
corepressor activity
225141_at 4775 Nuclear factor of activated T cells,
cytoplasmic, calcineurin-
dependent 3
Biologic process Inflammatory response; nucleus; regulation of
transcription from Pol II promoter; transcription
coactivator activity; transcription factor activity
225951_s_at 1106 Chromodomain helicase DNA-binding
protein 2
Biologic process ATP binding; ATP-dependent DNA helicase activity;
chromatin; chromatin assembly/disassembly;
chromatin binding; chromosome organization
and biogenesis (sensu Eukarya); helicase
activity; hydrolase activity; nucleus; regulation
of transcription from Pol II promoter
226933_s_at 3400 Inhibitor of DNA binding 4, dominant-
negative helix – loop–helix protein
Biologic process Nucleus; regulation of transcription from Pol II
promoter; transcription corepressor activity
230657_at 9575 Clock homolog (mouse) Biologic process Circadian rhythm; nucleus; regulation of transcription
from Pol II promoter; response to photoperiod;
signal transducer activity; signal transduction;
transcription factor activity
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
236133_x_at 9534 Zinc finger protein 254 Biologic process DNA binding; negative regulation of transcription
from Pol II promoter; nucleus; regulation of
transcription, DNA-dependent
242937_at 3607 Interleukin enhancer–binding factor 1 Biologic process RNA polymerase II transcription factor activity;
nucleus; regulation of transcription from Pol II
promoter; transcription factor activity
Record count = 22
Cell migration
202305_s_at 9637 Fasciculation and elongation
protein ~ 2 (zygin II)
Biologic process Axon guidance; cellular component unknown;
hemopoiesis; molecular function unknown;
neurogenesis; signal transduction
203381_s_at 348 Apolipoprotein E Biologic process Antioxidant activity; apolipoprotein E receptor
binding; b-amyloid binding; cholesterol homeostasis;
circulation; cytoplasm; cytoskeleton organization
and biogenesis; extracellular; heparin binding;
induction of apoptosis; intracellular transport;
learning and/or memory; lipid binding; lipid transport;
lipid transporter activity; lipoprotein metabolism;
low-density lipoprotein receptor binding; regulation
of axon extension; regulation of neuronal synaptic
plasticity; response to reactive oxygen species;
synaptic transmission, cholinergic; H protein binding
203382_s_at 348 Apolipoprotein E Biologic process Antioxidant activity; apolipoprotein E receptor binding;
b-amyloid binding; cholesterol homeostasis;
circulation; cytoplasm; cytoskeleton organization
and biogenesis; extracellular; heparin binding;
induction of apoptosis; intracellular transport;
learning and/or memory; lipid binding; lipid transport;
lipid transporter activity; lipoprotein metabolism;
low-density lipoprotein receptor binding; regulation
of axon extension; regulation of neuronal synaptic
plasticity; response to reactive oxygen species;
synaptic transmission, cholinergic; H protein binding
209946_at 7424 Vascular endothelial growth factor C Biologic process Angiogenesis; cell proliferation; growth factor activity;
lymph gland development; membrane; positive
regulation of cell proliferation; regulation of cell cycle;
signal transduction; substrate-bound cell migration
211509_s_at 57142 Reticulon 4 Biologic process Endoplasmic reticulum; integral to endoplasmic
reticulum membrane; molecular function unknown;
negative regulation of antiapoptosis; negative
regulation of axon extension; nuclear membrane;
protein binding; regulation of apoptosis
217838_s_at 51466 Enah/Vasp– like Biologic process F-actin capping activity; SH3-domain binding; actin
filament –based movement; actin nucleation; actin
polymerization and/or depolymerization; axon guidance;
cell surface receptor – linked signal transduction;
cytoplasm; focal adhesion; lamellipodium;
neurogenesis; platelet activation; profilin binding
222877_at 8828 Neuropilin 2 Biologic process Axon guidance; cell adhesion; electron transport;
electron transporter activity; integral to membrane;
membrane fraction; neurogenesis; receptor activity;
vascular endothelial growth factor receptor activity
231183_s_at 182 Jagged 1 (Alagille syndrome) Biologic process Notch binding; Notch signaling pathway; angiogenesis;
calcium ion binding; cell communication; cell
fate determination; development; endothelial cell
differentiation; extracellular; growth factor activity;
hemopoiesis; integral to plasma membrane;
keratinocyte differentiation; myoblast differentiation;
neurogenesis; regulation of cell migration; regulation
of cell proliferation; structural molecule activity
Record count = 8
mRNA processing
200020_at 23435 TAR DNA-binding protein Biologic process RNA binding; microtubule binding; mitosis; nuclear
mRNA splicing by spliceosome; nucleus; regulation
of transcription, DNA-dependent; transcription
factor activity; transcription from Pol II promoter
201054_at 10949 Heterogeneous nuclear
ribonucleoprotein A0
Biologic process RNA binding; heterogeneous nuclear ribonucleoprotein
complex; mRNA processing
202683_s_at 8731 RNA (guanine-7-) methyltransferase Biologic process RNA binding; mRNA (guanine-N 7-)-methyltransferase
activity; mRNA capping; methyltransferase activity;
nucleus; transferase activity
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
202858_at 7307 U2(RNU2) small nuclear RNA auxiliary
factor 1
Biologic process Cajal body; RNA binding; RNA splicing; nuclear
mRNA splicing by spliceosome; pre-mRNA splicing
factor activity; spliceosome complex
202899_s_at 6428 Splicing factor, arginine/serine– rich 3 Biologic process RNA binding; nuclear mRNA splicing by spliceosome;
nucleus
204208_at 8732 RNA guanylyltransferase and
5V-phosphatase
Biologic process Hydrolase activity; mRNA capping; mRNA
guanylyltransferase activity; nucleotidyltransferase
activity; nucleus; phosphoprotein phosphatase
activity; polynucleotide 5V-phosphatase activity;
protein amino acid dephosphorylation; transferase
activity
206052_s_at 7884 Stem– loop (histone) –binding protein Biologic process Histone mRNA 3V-end processing; mRNA binding;
nucleus; ribonucleoprotein complex
208672_s_at 6428 Splicing factor, arginine/serine– rich 3 Biologic process RNA binding; nuclear mRNA splicing by spliceosome;
nucleus
210172_at 7536 Splicing factor 1 Biologic process DNA binding; RNA binding; RNA polymerase II
transcription factor activity; biologic process
unknown; metal ion binding; nuclear mRNA
splicing by spliceosome; nucleus; regulation of
transcription, DNA-dependent; spliceosome
complex; transcription corepressor activity
211115_x_at 8487 Survival of motor neuron protein–
interacting protein 1
Biologic process Cytoplasm; pre-mRNA splicing factor activity;
spliceosome assembly; spliceosome complex
212030_at 58517 RNA-binding region (RNP1, RRM)
containing 7
Biologic process Cellular component unknown; mRNA binding; nuclear
mRNA splicing by spliceosome
213575_at 29896 Transformer-2 a Biologic process RNA binding; nuclear mRNA splicing by spliceosome;
nucleus; pre-mRNA splicing factor activity
213593_s_at 29896 Transformer-2 a Biologic process RNA binding; nuclear mRNA splicing by spliceosome;
nucleus; pre-mRNA splicing factor activity
213852_at 9939 RNA-binding motif protein 8A Biologic process Biologic process unknown; cytoplasm; mRNA
binding; mRNA nucleus export; nuclear
mRNA splicing by spliceosome; nucleus;
transport
214814_at 91746 Splicing factor YT521-B Biologic process Nuclear mRNA splicing by spliceosome; nucleus
221742_at 10658 CUG triplet repeat, RNA-binding
protein 1
Biologic process BRE binding; RNA interference; embryonic
development; germ-cell development; mRNA
processing; mRNA splice site selection; nucleus;
pre-mRNA splicing factor activity; ribonucleoprotein
complex; translation repressor activity, nucleic
acid binding
221860_at 3191 Heterogeneous nuclear
ribonucleoprotein L
Biologic process RNA binding; heterogeneous nuclear ribonucleoprotein
complex; mRNA processing; nucleoplasm
223331_s_at 11218 DEAD (Asp–Glu–Ala–Asp) box
polypeptide 20
Biologic process ATP binding; ATP-dependent RNA helicase activity;
DNA binding; assembly of spliceosomal tri-snRNP;
cytoskeleton; mRNA processing; spliceosome
complex
225593_at 84967 U7 snRNP–specific Sm-like protein
LSM10
Biologic process RNA binding; nuclear mRNA splicing by spliceosome;
nucleus; pre-mRNA splicing factor activity; small
nucleolar ribonucleoprotein complex
226898_s_at 6421 Splicing factor proline/glutamine– rich
(polypyrimidine tract –binding
protein–associated)
Biologic process DNA binding; RNA binding; RNA splicing; nuclear
mRNA splicing by spliceosome; nucleus; pre-mRNA
splicing factor activity
227223_at 9584 RNA-binding region (RNP1, RRM)
containing 2
Biologic process RNA binding; nuclear mRNA splicing by spliceosome;
nucleus; regulation of transcription, DNA-dependent
229303_at 23451 Splicing factor 3b, subunit 1; 155 kDa Biologic process Nuclear mRNA splicing by spliceosome; pre-mRNA
splicing factor activity; spliceosome complex
233878_s_at 22803 5V–3V Exoribonuclease 2 Biologic process 5V–3V Exoribonuclease activity; DNA recombination;
DNA repair; RNA binding; RNA metabolism; cell
growth; exonuclease activity; hydrolase activity;
mRNA processing; microtubule-based process;
nucleus; spermatogenesis
Record count = 23
Eukaryotic translation initiation factor 3 complex
200005_at 8664 Eukaryotic translation initiation
factor 3, subunit 7 ~; 66/67 kDa
Cellular component Eukaryotic translation initiation factor 3 complex;
protein biosynthesis; regulation of translational
initiation; translation initiation factor activity
200595_s_at 8661 Eukaryotic translation initiation
factor 3, subunit 10 u; 150/170 kDa
Cellular component Eukaryotic translation initiation factor 3 complex;
protein biosynthesis; regulation of translational
initiation; translation initiation factor activity
200647_x_at 8663 Eukaryotic translation initiation
factor 3, subunit 8; 110 kDa
Cellular component Eukaryotic translation initiation factor 3 complex;
protein biosynthesis; regulation of translational
initiation; translation initiation factor activity
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
208985_s_at 8669 Eukaryotic translation initiation
factor 3, subunit 1 a; 35 kDa
Cellular component Eukaryotic translation initiation factor 3 complex;
protein biosynthesis; regulation of translational
initiation; translation initiation factor activity
Record count = 4
Transmembrane receptor protein serine/threonine kinase signaling protein activity
204790_at 4092 MAD, mothers against
decapentaplegic homolog 7
(Drosophila)
Molecular function Intracellular; protein binding; receptor signaling
protein serine/threonine kinase signaling
protein activity; regulation of transcription,
DNA-dependent; response to stress; transforming
growth factor-b receptor signaling pathway;
transforming growth factor-b receptor, inhibitory
cytoplasmic mediator activity
207069_s_at 4091 MAD, mothers against
decapentaplegic homolog 6
(Drosophila)
Molecular function Intracellular; protein binding; receptor signaling
protein serine/threonine kinase signaling protein
activity; regulation of transcription, DNA-dependent;
signal transducer activity; transforming growth
factor-b receptor, inhibitory cytoplasmic mediator
activity
209112_at 1027 Cyclin-dependent kinase inhibitor
1B (p27, Kip1)
Molecular function Cell cycle arrest; cyclin-dependent protein kinase
inhibitor activity; negative regulation of cell
proliferation; nucleus; regulation of CDK activity;
transforming growth factor-b receptor, cytoplasmic
mediator activity
Record count = 3
GTPase activity
200750_s_at 5901 RAN, member RAS oncogene family Molecular function DNA metabolism; GTP binding; RAN small
monomeric GTPase activity; RNA nucleus export;
chromatin; intracellular protein transport; mitotic
spindle assembly; nuclear pore; nucleus; protein
transporter activity; protein nucleus export;
regulation of cell cycle; signal transduction;
small GTPase–mediated signal transduction
200823_x_at 6159 Ribosomal protein L29 Molecular function GTPase activity; small GTPase–mediated signal
transduction
202046_s_at 2909 Glucocorticoid receptor DNA-binding
factor 1
Molecular function DNA binding; GTP binding; GTPase activator
activity; negative regulation of cell cycle; negative
regulation of transcription; nucleus; regulation of
eye photoreceptor cell development; regulation
of transcription, DNA-dependent; small GTPase–
mediated signal transduction; small monomeric
GTPase activity; transcriptional repressor activity
202641_at 403 ADP ribosylation factor – like 3 Molecular function G-protein–coupled receptor protein signaling
pathway; GTP binding; signal transducer activity;
small GTPase–mediated signal transduction;
small monomeric GTPase activity
208290_s_at 1983 Eukaryotic translation initiation factor 5 Molecular function GTP binding; GTPase activity; cytosol; protein
biosynthesis; regulation of translational initiation;
translation initiation factor activity
208705_s_at 1983 Eukaryotic translation initiation factor 5 Molecular function GTP binding; GTPase activity; cytosol; protein
biosynthesis; regulation of translational initiation;
translation initiation factor activity
212589_at 22800 Related RAS viral (r-ras) oncogene
homolog 2
Molecular function GTP binding; RAS small monomeric GTPase activity;
cell growth and/or maintenance; endoplasmic
reticulum; plasma membrane; small GTPase–
mediated signal transduction
213404_s_at 6009 Ras homolog enriched in brain Molecular function GTP binding; membrane; signal transduction;
small GTPase–mediated signal transduction;
small monomeric GTPase activity
213969_x_at 6159 Ribosomal protein L29 Molecular function GTPase activity; small GTPase–mediated signal
transduction
214435_x_at 5898 v-ral simian leukemia viral oncogene
homolog A (ras-related)
Molecular function GTP binding; chemotaxis; protein binding; signal
transduction; small GTPase–mediated signal
transduction; small monomeric GTPase activity
215506_s_at 9077 ras homolog gene family, member I Molecular function GTP binding; imprinting; regulation of CDK activity;
small GTPase–mediated signal transduction;
small monomeric GTPase activity
217043_s_at 55669 Mitofusin 1 Molecular function GTPase activity; biologic process unknown; integral
to membrane
217976_s_at 51143 Dynein, cytoplasmic, light intermediate
polypeptide 1
Molecular function GTP binding; motor activity; small GTPase–mediated
signal transduction; small monomeric GTPase
activity
Table W2. (continued ).
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221014_s_at 83452 RAB33B, member RAS oncogene
family
Molecular function GTP binding; Golgi apparatus; RAB small monomeric
GTPase activity; intracellular protein transport;
protein transporter activity; small GTPase–mediated
signal transduction
221808_at 9367 RAB9A, member RAS oncogene
family
Molecular function GTP binding; Golgi apparatus; RAB small monomeric
GTPase activity; intracellular protein transport;
protein transporter activity; small GTPase–mediated
signal transduction
222514_at 64121 Ras-related GTP binding C Molecular function GDP binding; RNA splicing; apoptosis; cell growth;
cell growth and/or maintenance; cytoplasm;
heterotrimeric G-protein complex; magnesium
ion binding; nucleus; protein binding; protein
heterodimerization activity; small GTPase–
mediated signal transduction; small
monomeric GTPase activity; transcription
222700_at 64225 ADP ribosylation factor – like
6– interacting protein 2
Molecular function GTP binding; GTPase activity; immune response
224880_at 5898 v-ral simian leukemia viral oncogene
homolog A (ras-related)
Molecular function GTP binding; chemotaxis; protein binding; signal
transduction; small GTPase–mediated signal
transduction; small monomeric GTPase activity
225153_at 85476 Mitochondrial elongation factor G1 Molecular function GTP binding; protein biosynthesis; protein-
synthesizing GTPase activity
225930_at 28512 I-nB– interacting Ras-like protein 1 Molecular function GTP binding; NIK-I-nB/NF-nB cascade; cellular
component unknown; small GTPase–mediated
signal transduction; small monomeric GTPase
activity
226633_at 51762 RAB8B, member RAS oncogene
family
Molecular function GTP binding; RAB small monomeric GTPase activity;
cellular component unknown; intracellular protein
transport; protein transporter activity; small
GTPase–mediated signal transduction
226859_at 2790 Guanine nucleotide–binding protein
(G protein), g 10
Molecular function G-protein–coupled receptor protein signaling
pathway; heterotrimeric G-protein GTPase activity;
heterotrimeric G-protein complex; signal transducer
activity; signal transduction
240111_at 22836 U-Related BTB domain containing 3 Molecular function U Small monomeric GTPase activity; biologic process
unknown; intracellular; protein binding
243496_at 22931 RAB18, member RAS oncogene
family
Molecular function GTP binding; RAB small monomeric GTPase
activity; cellular component unknown; endocytosis;
intracellular protein transport; protein transporter
activity; small GTPase–mediated signal
transduction
Record count = 24
Angiogenesis
209946_at 7424 Vascular endothelial growth factor C Biologic process Angiogenesis; cell proliferation; growth factor
activity; lymph gland development; membrane;
positive regulation of cell proliferation; regulation
of cell cycle; signal transduction; substrate-bound
cell migration
212171_x_at 7422 Vascular endothelial growth factor Biologic process Angiogenesis; cell proliferation; extracellular; growth
factor activity; heparin binding; homophilic cell
adhesion; membrane; positive regulation of cell
proliferation; regulation of cell cycle; response
to stress; signal transduction; soluble fraction;
vascular endothelial growth factor receptor binding
216368_s_at 1285 Collagen, type IV, a 3 (Goodpasture
antigen)
Biologic process Caspase activation; cell adhesion; cell proliferation;
cell surface receptor linked signal transduction;
circulation; collagen type IV; extracellular matrix
structural constituent; induction of apoptosis; integrin
binding; metalloendopeptidase inhibitor activity;
negative regulation of angiogenesis; negative
regulation of cell proliferation; perception of sound;
protein binding
226497_s_at 2321 Fms-related tyrosine kinase 1
(vascular endothelial growth
factor/vascular permeability
factor receptor)
Biologic process ATP binding; angiogenesis; extracellular space;
integral to plasma membrane; positive regulation
of cell proliferation; pregnancy; protein amino acid
phosphorylation; receptor activity; transferase
activity; transmembrane receptor protein-tyrosine
kinase signaling pathway; vascular endothelial
growth factor receptor activity
227106_at 4327 Matrix metalloproteinase 19 Biologic process Angiogenesis; collagen catabolism; extracellular
matrix; hydrolase activity; metalloendopeptidase
activity; zinc ion binding
Table W2. (continued ).
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231183_s_at 182 Jagged 1 (Alagille syndrome) Biologic process Notch binding; Notch signaling pathway; angiogenesis;
calcium ion binding; cell communication; cell
fate determination; development; endothelial cell
differentiation; extracellular; growth factor activity;
hemopoiesis; integral to plasma membrane;
keratinocyte differentiation; myoblast differentiation;
neurogenesis; regulation of cell migration; regulation
of cell proliferation; structural molecule activity
Record count = 6
Small GTPase– regulatory/interacting protein activity
200008_s_at 2665 GDP dissociation inhibitor 2 Molecular function GTPase activator activity; RAB GDP dissociation
inhibitor activity; protein transport
200009_at 2665 GDP dissociation inhibitor 2 Molecular function GTPase activator activity; RAB GDP dissociation
inhibitor activity; protein transport
200993_at 10527 Importin 7 Molecular function RAN protein binding; cytoplasm; nuclear pore;
nucleus; protein transporter activity; protein-nucleus
import, docking; signal transduction; small
GTPase– regulatory/interacting protein activity;
soluble fraction
200995_at 10527 Importin 7 Molecular function RAN protein binding; cytoplasm; nuclear pore;
nucleus; protein transporter activity; protein-nucleus
import, docking; signal transduction; small
GTPase– regulatory/interacting protein activity;
soluble fraction
201830_s_at 10276 Neuroepithelial cell – transforming
gene 1
Molecular function Guanyl nucleotide exchange factor activity; signal
transduction
206571_s_at 9448 Mitogen-activated protein kinase
kinase kinase kinase 4
Molecular function ATP binding; cellular component unknown; protein
amino acid phosphorylation; protein kinase cascade;
protein serine/threonine kinase activity; response
to stress; small GTPase– regulatory/interacting
protein activity; transferase activity
212870_at 6655 Son of sevenless homolog
2 (Drosophila)
Molecular function Cellular component unknown; guanyl nucleotide
exchange factor activity; small GTPase–mediated
signal transduction
216115_at 4763 Neurofibromin 1 (neurofibromatosis,
von Recklinghausen disease,
Watson disease)
Molecular function RAS protein signal transduction; Ras GTPase
activator activity; biologic process unknown;
cell growth and/or maintenance; cellular
component unknown; cytoplasm; enzyme inhibitor
activity; molecular function unknown; negative
regulation of cell cycle; negative regulation of
cell proliferation
216266_s_at 10565 Brefeldin A– inhibited guanine
nucleotide exchange protein 1
Molecular function Exocytosis; guanyl nucleotide exchange factor activity
217808_s_at 79109 Mitogen-activated protein kinase–
associated protein 1
Molecular function Ras interactor activity; biologic process unknown;
cellular component unknown
227971_at 203447 Hypothetical protein DKFZp686A17109 Molecular function ATP binding; protein amino acid phosphorylation;
protein serine/threonine kinase activity; small
GTPase– regulatory/interacting protein activity
228109_at 5924 Ras protein–specific guanine
nucleotide– releasing factor 2
Molecular function Guanyl nucleotide exchange factor activity; small
GTPase–mediated signal transduction
229642_at 8874 U-Guanine nucleotide exchange factor
(GEF) 7
Molecular function Guanyl nucleotide exchange factor activity; signal
transduction
230078_at 51735 PDZ domain–containing guanine
nucleotide exchange factor (GEF) 2
Molecular function GTP-dependent protein binding; RAS protein signal
transduction; guanyl nucleotide exchange factor
activity; neuropeptide signaling pathway; plasma
membrane; protein binding; small GTPase–
mediated signal transduction
230669_at 5922 RAS p21 protein activator 2 Molecular function Ras GTPase activator activity; intracellular signaling
cascade
Record count = 15
Ubiquitin-protein ligase activity
200669_s_at 7323 Ubiquitin-conjugating enzyme E2D 3
(UBC4/5 homolog, yeast)
Molecular function Ligase activity; ubiquitin-conjugating enzyme activity;
ubiquitin cycle; ubiquitin-dependent protein
catabolism; ubiquitin-protein ligase activity
200676_s_at 7332 Ubiquitin-conjugating enzyme E2L 3 Molecular function Enzyme binding; ligase activity; ubiquitin-conjugating
enzyme activity; ubiquitin cycle; ubiquitin ligase
complex; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
201344_at 7322 Ubiquitin-conjugating enzyme E2D 2
(UBC4/5 homolog, yeast)
Molecular function Ligase activity; ubiquitin-conjugating enzyme activity;
ubiquitin cycle; ubiquitin-dependent protein
catabolism; ubiquitin-protein ligase activity
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
201546_at 9320 Thyroid hormone receptor interactor 12 Molecular function Cellular component unknown; cytosol; intracellular;
ligase activity; protein ubiquitination; thyroid
hormone receptor binding; ubiquitin-protein
ligase activity
201899_s_at 7319 Ubiquitin-conjugating enzyme E2A
RAD6 homolog)
Molecular function Ligase activity; nucleus; postreplication repair;
ubiquitin-conjugating enzyme activity; ubiquitin
cycle; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
202334_s_at 7320 Ubiquitin-conjugating enzyme E2B
(RAD6 homolog)
Molecular function Ligase activity; nucleus; postreplication repair;
ubiquitin-conjugating enzyme activity; ubiquitin
cycle; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
210024_s_at 10477 Ubiquitin-conjugating enzyme E2E 3
(UBC4/5 homolog, yeast)
Molecular function Ligase activity; ubiquitin-conjugating enzyme
activity; ubiquitin cycle; ubiquitin-protein ligase
activity
213535_s_at 7329 Ubiquitin-conjugating enzyme E2I
(UBC9 homolog, yeast)
Molecular function Ligase activity; synaptonemal complex; ubiquitin-
conjugating enzyme activity; ubiquitin cycle;
ubiquitin-dependent protein catabolism; ubiquitin-
protein ligase activity
225209_s_at 118424 Ubiquitin-conjugating enzyme E2,
J2 (UBC6 homolog, yeast)
Molecular function Ligase activity; ubiquitin-conjugating enzyme
activity; ubiquitin cycle; ubiquitin-protein ligase
activity
230411_at 7336 Ubiquitin-conjugating enzyme E2
variant 2
Molecular function Cell proliferation; ligase activity; protein
polyubiquitination; regulation of DNA repair;
regulation of cell cycle; ubiquitin-conjugating
enzyme activity; ubiquitin cycle; ubiquitin-protein
ligase activity
Record count = 10
Antiapoptosis
202036_s_at 6422 Secreted frizzled– related protein 1 Biologic process Antiapoptosis; development; extracellular space;
membrane; morphogenesis; signal transduction;
transmembrane receptor activity
202443_x_at 4853 Notch homolog 2 (Drosophila) Biologic process Notch signaling pathway; antiapoptosis; calcium
ion binding; cell cycle arrest; cell differentiation;
cell fate determination; cell growth; cell surface;
determination of left/right symmetry; hemopoiesis;
induction of apoptosis; integral to plasma
membrane; ligand-regulated transcription factor
activity; morphogenesis of epithelial sheet; negative
regulation of cell proliferation; neurogenesis;
nucleus; positive regulation of RAS protein
signal transduction; protein binding; protein
heterodimerization activity; receptor activity;
regulation of development; regulation of
transcription, DNA-dependent; stem cell
maintenance; transcription regulator activity
202643_s_at 7128 Tumor necrosis factor-a– induced
protein 3
Biologic process DNA binding; antiapoptosis; apoptosis; negative
regulation of transcription; nucleus; protein binding;
zinc ion binding
208309_s_at 10892 Mucosa-associated lymphoid tissue
lymphoma translocation gene 1
Biologic process Activation of NF-nB– inducing kinase; antiapoptosis;
caspase activity; defense response; intracellular;
peptidase activity; protein binding; proteolysis and
peptidolysis; signal transduction
211509_s_at 57142 Reticulon 4 Biologic process Endoplasmic reticulum; integral to endoplasmic
reticulum membrane; molecular function unknown;
negative regulation of antiapoptosis; negative
regulation of axon extension; nuclear membrane;
protein binding; regulation of apoptosis
211833_s_at 581 BCL2-associated X protein Biologic process Apoptosis; apoptotic mitochondrial changes; cellular
component unknown; germ-cell development;
induction of apoptosis; induction of apoptosis
by extracellular signals; integral to membrane;
molecular function unknown; negative regulation
of cell cycle; negative regulation of survival gene
product activity; regulation of apoptosis
221478_at 665 BCL2/adenovirus E1B 19 kDa–
interacting protein 3– like
Biologic process Apoptosis; induction of apoptosis; integral to
membrane; mitochondrion; negative regulation
of survival gene product activity
224635_s_at 57448 Baculoviral IAP repeat –containing
6 (apollon)
Biologic process Antiapoptosis; apoptosis; cellular component
unknown; cysteine protease inhibitor activity;
intracellular; ligase activity; ubiquitin-conjugating
enzyme activity; ubiquitin cycle
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
225984_at 5562 Protein kinase, AMP-activated,
a 1 catalytic subunit
Biologic process ATP binding; activation of MAPK; cAMP-dependent
protein kinase activity; cholesterol biosynthesis;
eukaryotic elongation factor-2 kinase activator
activity; fatty acid biosynthesis; intracellular;
negative regulation of glucosylceramide
biosynthesis; negative regulation of protein
biosynthesis; positive regulation of antiapoptosis;
positive regulation of cholesterol biosynthesis;
positive regulation of fatty acid oxidation;
positive regulation of gluconeogenesis; positive
regulation of glucose import; protein amino
acid phosphorylation; protein serine/threonine
kinase activity; response to hypoxia; transferase
activity
37226_at 662 BCL2/adenovirus E1B 19 kDa–
interacting protein 1
Biologic process Antiapoptosis; apoptosis; integral to membrane;
protein binding
Record count = 10
Chromatin remodeling
201483_s_at 6827 Suppressor of Ty 4 homolog 1
(S. cerevisiae)
Biologic process Chromatin remodeling; nucleus; regulation of
transcription from Pol II promoter; transcription;
transcription factor activity
203428_s_at 25842 ASF1 anti –silencing function 1
homolog A (S. cerevisiae)
Biologic process Chromatin binding; loss of chromatin silencing;
nucleus
203845_at 8850 p300/CBP–associated factor Biologic process N-Acetyltransferase activity; cell cycle; cell
cycle arrest; chromatin remodeling; histone
deacetylase activity; negative regulation of
cell proliferation; nucleus; protein amino acid
acetylation; regulation of transcription, DNA-
dependent; transcription cofactor activity;
transferase activity
225181_at 57492 AT-rich interactive domain 1B
(SWI1-like)
Biologic process DNA binding; SWI/SNF complex; biologic process
unknown; cellular component unknown;
chromatin-mediated maintenance of transcription;
intracellular; molecular function unknown; protein
binding; transcription coactivator activity
231764_at 54108 Chromatin accessibility complex 1 Biologic process DNA binding; chromatin accessibility complex;
chromatin remodeling; e DNA polymerase activity;
e DNA polymerase complex; nucleus
239585_at 8850 p300/CBP–associated factor Biologic process N-Acetyltransferase activity; cell cycle; cell cycle
arrest; chromatin remodeling; histone deacetylase
activity; negative regulation of cell proliferation;
nucleus; protein amino acid acetylation; regulation
of transcription, DNA-dependent; transcription
cofactor activity; transferase activity
Record count = 6
Negative regulation of apoptosis
202036_s_at 6422 Secreted frizzled– related protein 1 Biologic process Antiapoptosis; development; extracellular space;
membrane; morphogenesis; signal transduction;
transmembrane receptor activity
202443_x_at 4853 Notch homolog 2 (Drosophila) Biologic process Notch signaling pathway; antiapoptosis; calcium
ion binding; cell cycle arrest; cell differentiation;
cell fate determination; cell growth; cell
surface; determination of left/right symmetry;
hemopoiesis; induction of apoptosis; integral to
plasma membrane; ligand-regulated transcription
factor activity; morphogenesis of epithelial
sheet; negative regulation of cell proliferation;
neurogenesis; nucleus; positive regulation
of RAS protein signal transduction; protein
binding; protein heterodimerization activity;
receptor activity; regulation of development;
regulation of transcription, DNA-dependent;
stem cell maintenance; transcription regulator
activity
202643_s_at 7128 Tumor necrosis factor-a– induced
protein 3
Biologic process DNA binding; antiapoptosis; apoptosis; negative
regulation of transcription; nucleus; protein binding;
zinc ion binding
208309_s_at 10892 Mucosa-associated lymphoid tissue
lymphoma translocation gene 1
Biologic process Activation of NF-nB– inducing kinase; antiapoptosis;
caspase activity; defense response; intracellular;
peptidase activity; protein binding; proteolysis and
peptidolysis; signal transduction
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
211509_s_at 57142 Reticulon 4 Biologic process Endoplasmic reticulum; integral to endoplasmic
reticulum membrane; molecular function
unknown; negative regulation of antiapoptosis;
negative regulation of axon extension; nuclear
membrane; protein binding; regulation of
apoptosis
211833_s_at 581 BCL2-associated X protein Biologic process Apoptosis; apoptotic mitochondrial changes;
cellular component unknown; germ-cell
development; induction of apoptosis; induction
of apoptosis by extracellular signals; integral
to membrane; molecular function unknown;
negative regulation of cell cycle; negative
regulation of survival gene product activity;
regulation of apoptosis
221478_at 665 BCL2/adenovirus E1B 19 kDa–
interacting protein 3– like
Biologic process Apoptosis; induction of apoptosis; integral to
membrane; mitochondrion; negative regulation
of survival gene product activity
224635_s_at 57448 Baculoviral IAP repeat –containing
6 (apollon)
Biologic process Antiapoptosis; apoptosis; cellular component
unknown; cysteine protease inhibitor activity;
intracellular; ligase activity; ubiquitin-conjugating
enzyme activity; ubiquitin cycle
225984_at 5562 Protein kinase, AMP-activated,
a 1 catalytic subunit
Biologic process ATP binding; activation of MAPK; cAMP-dependent
protein kinase activity; cholesterol biosynthesis;
eukaryotic elongation factor-2 kinase activator
activity; fatty acid biosynthesis; intracellular; negative
regulation of glucosylceramide biosynthesis;
negative regulation of protein biosynthesis; positive
regulation of antiapoptosis; positive regulation
of cholesterol biosynthesis; positive regulation
of fatty acid oxidation; positive regulation of
gluconeogenesis; positive regulation of glucose
import; protein amino acid phosphorylation; protein
serine/threonine kinase activity; response to
hypoxia; transferase activity
37226_at 662 BCL2/adenovirus E1B 19 kDa–
interacting protein 1
Biologic process Antiapoptosis; apoptosis; integral to membrane;
protein binding
Record count = 10
Regulation of gene expression, epigenetic
203428_s_at 25842 ASF1 anti –silencing function 1
homolog A (S. cerevisiae)
Biologic process Chromatin binding; loss of chromatin silencing;
nucleus
215506_s_at 9077 Ras homolog gene family, member I Biologic process GTP binding; imprinting; regulation of CDK activity;
small GTPase–mediated signal transduction;
small monomeric GTPase activity
221742_at 10658 CUG triplet repeat, RNA-binding
protein 1
Biologic process BRE binding; RNA interference; embryonic
development; germ-cell development; mRNA
processing; mRNA splice site selection; nucleus;
pre-mRNA splicing factor activity; ribonucleoprotein
complex; translation repressor activity, nucleic
acid binding
222526_at 54815 p66 a Biologic process DNA methylation; NuRD complex; negative regulation
of transcription, DNA-dependent; nucleus; protein
binding, bridging; transcription factor activity;
transcriptional repressor activity
225181_at 57492 AT-rich interactive domain 1B
(SWI1-like)
Biologic process DNA binding; SWI/SNF complex; biologic process
unknown; cellular component unknown;
chromatin-mediated maintenance of transcription;
intracellular; molecular function unknown; protein
binding; transcription coactivator activity
234294_x_at 54815 p66 a Biologic process DNA methylation; NuRD complex; negative regulation
of transcription, DNA-dependent; nucleus; protein
binding, bridging; transcription factor activity;
transcriptional repressor activity
Record count = 6
Ubiquitin-dependent protein catabolism
200669_s_at 7323 Ubiquitin-conjugating enzyme E2D 3
(UBC4/5 homolog, yeast)
Biologic process Ligase activity; ubiquitin-conjugating enzyme
activity; ubiquitin cycle; ubiquitin-dependent protein
catabolism; ubiquitin-protein ligase activity
200676_s_at 7332 Ubiquitin-conjugating enzyme E2L 3 Biologic process Enzyme binding; ligase activity; ubiquitin-conjugating
enzyme activity; ubiquitin cycle; ubiquitin ligase
complex; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
201344_at 7322 Ubiquitin-conjugating enzyme E2D 2
(UBC4/5 homolog, yeast)
Biologic process Ligase activity; ubiquitin-conjugating enzyme activity;
ubiquitin cycle; ubiquitin-dependent protein
catabolism; ubiquitin-protein ligase activity
201880_at 25820 Ariadne homolog, ubiquitin-conjugating
enzyme E2-binding protein,
1 (Drosophila)
Biologic process Enzyme binding; ubiquitin ligase complex;
ubiquitin-dependent protein catabolism; ubiquitin-like
protein ligase activity
201899_s_at 7319 Ubiquitin-conjugating enzyme E2A
(RAD6 homolog)
Biologic process Ligase activity; nucleus; postreplication repair;
ubiquitin-conjugating enzyme activity; ubiquitin
cycle; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
202334_s_at 7320 Ubiquitin-conjugating enzyme E2B
(RAD6 homolog)
Biologic process Ligase activity; nucleus; postreplication repair;
ubiquitin-conjugating enzyme activity; ubiquitin
cycle; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
206405_x_at 9098 Ubiquitin-specific protease 6
(Tre-2 oncogene)
Biologic process Biologic process unknown; cell growth and/or
maintenance; cellular component unknown;
cysteine-type endopeptidase activity; hydrolase
activity; lysosome; molecular function unknown;
nucleic acid binding; protein modification; ubiquitin
thiolesterase activity; ubiquitin-dependent protein
catabolism
209475_at 9958 Ubiquitin-specific protease 15 Biologic process Cysteine-type endopeptidase activity; hydrolase
activity; peptidase activity; ubiquitin cycle;
ubiquitin thiolesterase activity; ubiquitin-dependent
protein catabolism; ubiquitin-specific protease
activity
211746_x_at 5682 Proteasome (prosome, macropain)
subunit, a type, 1
Biologic process RNA binding; endopeptidase activity; polysome;
proteasome core complex (sensu Eukarya);
ubiquitin-dependent protein catabolism
213535_s_at 7329 Ubiquitin-conjugating enzyme E2I
(UBC9 homolog, yeast)
Biologic process Ligase activity; synaptonemal complex;
ubiquitin-conjugating enzyme activity; ubiquitin
cycle; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
230761_at 7874 Ubiquitin-specific protease 7
(herpes virus–associated)
Biologic process Cysteine-type endopeptidase activity; hydrolase
activity; nucleus; ubiquitin thiolesterase activity;
ubiquitin-dependent protein catabolism;
ubiquitin-specific protease activity
232219_x_at 27005 Ubiquitin-specific protease 21 Biologic process Cellular component unknown; cysteine-type
endopeptidase activity; hydrolase activity; protein
modification; ubiquitin thiolesterase activity;
ubiquitin-dependent protein catabolism
Record count = 12
Regulation of translational initiation
200005_at 8664 Eukaryotic translation initiation
factor 3, subunit 7 ~; 66/67 kDa
Biologic process Eukaryotic translation initiation factor 3 complex;
protein biosynthesis; regulation of translational
initiation; translation initiation factor activity
200595_s_at 8661 Eukaryotic translation initiation
factor 3, subunit 10 u; 150/170 kDa
Biologic process Eukaryotic translation initiation factor 3 complex;
protein biosynthesis; regulation of translational
initiation; translation initiation factor activity
200647_x_at 8663 Eukaryotic translation initiation
factor 3, subunit 8; 110 kDa
Biologic process Eukaryotic translation initiation factor 3 complex;
protein biosynthesis; regulation of translational
initiation; translation initiation factor activity
202021_x_at 10209 Putative translation initiation factor Biologic process Cell growth and/or maintenance; cellular component
unknown; cytoplasm; regulation of protein
biosynthesis; regulation of translation; regulation
of translational initiation; response to stress;
translation initiation factor activity; translational
initiation
208290_s_at 1983 Eukaryotic translation initiation
factor 5
Biologic process GTP binding; GTPase activity; cytosol; protein
biosynthesis; regulation of translational initiation;
translation initiation factor activity
208705_s_at 1983 Eukaryotic translation initiation
factor 5
Biologic process GTP binding; GTPase activity; cytosol; protein
biosynthesis; regulation of translational initiation;
translation initiation factor activity
208985_s_at 8669 Eukaryotic translation initiation
factor 3, subunit 1 a; 35 kDa
Biologic process Eukaryotic translation initiation factor 3 complex;
protein biosynthesis; regulation of translational
initiation; translation initiation factor activity
Record count = 7
Molecular function unknown
200718_s_at 6500 S-phase kinase–associated
protein 1A (p19A)
Molecular function Biologic process unknown; cellular component
unknown; molecular function unknown
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
201009_s_at 10628 Thioredoxin-interacting protein Molecular function Biologic process unknown; cellular component
unknown; molecular function unknown
201285_at 23608 Makorin, ring finger protein, 1 Molecular function Biologic process unknown; cellular component
unknown; molecular function unknown; nucleic
acid binding
201862_s_at 9208 Leucine-rich repeat (in FLII) –
interacting protein 1
Molecular function RNA polymerase II transcription factor activity; biologic
process unknown; cellular component unknown;
cytoskeleton; double-stranded RNA binding; molecular
function unknown; negative regulation of transcription;
nucleus; regulation of transcription from Pol II
promoter; transcriptional repressor activity
202130_at 8780 RIO kinase 3 (yeast) Molecular function Chromosome segregation; molecular function
unknown
202305_s_at 9637 Fasciculation and elongation
protein ~ 2 (zygin II)
Molecular function Axon guidance; cellular component unknown;
hemopoiesis; molecular function unknown;
neurogenesis; signal transduction
203333_at 22920 Kinesin-associated protein 3 Molecular function Endoplasmic reticulum; kinesin II complex; kinesin
binding; microtubule-based process; molecular
function unknown; protein complex assembly;
signal transduction
203635_at 10311 Down syndrome critical region gene 3 Molecular function Biologic process unknown; cellular component
unknown; intracellular protein transport; molecular
function unknown
203880_at 64091 Popeye domain containing 2 Molecular function Biologic process unknown; integral to membrane;
molecular function unknown
204383_at 8220 DiGeorge syndrome critical region
gene 14
Molecular function Molecular function unknown; neurogenesis; nucleus
204480_s_at 79095 Chromosome 9, open reading
frame 16
Molecular function Biologic process unknown; cellular component
unknown; molecular function unknown
204747_at 3437 Interferon-induced protein with
tetratricopeptide repeats 4
Molecular function Biologic process unknown; cellular component unknown;
immune response; molecular function unknown
204872_at 7091 Transducin-like enhancer of split 4
[E(sp1) homolog, Drosophila]
Molecular function Biologic process unknown; frizzled signaling pathway;
molecular function unknown; nucleus; regulation
of transcription, DNA-dependent
205172_x_at 1212 Clathrin, light polypeptide (Lcb) Molecular function Calcium ion binding; clathrin vesicle coat; coated pit;
intracellular protein transport; molecular function
unknown
205564_at 9506 G antigen, family C, 1 Molecular function Biologic process unknown; cellular component
unknown; molecular function unknown
206405_x_at 9098 Ubiquitin-specific protease 6
(Tre-2 oncogene)
Molecular function Biologic process unknown; cell growth and/or
maintenance; cellular component unknown;
cysteine-type endopeptidase activity; hydrolase
activity; lysosome; molecular function unknown;
nucleic acid binding; protein modification; ubiquitin
thiolesterase activity; ubiquitin-dependent protein
catabolism
206700_s_at 8284 Jumonji, AT-rich interactive domain 1D
(RBP2-like)
Molecular function DNA binding; biologic process unknown; cellular
component unknown; molecular function unknown;
nucleus; regulation of transcription, DNA-dependent;
spermatogenesis
207783_x_at 7178 Tumor protein, translationally
controlled 1
Molecular function Cytoplasm; extracellular space; molecular function
unknown
207974_s_at 6500 S-phase kinase–associated
protein 1A (p19A)
Molecular function Biologic process unknown; cellular component
unknown; molecular function unknown
208735_s_at 10106 CTD (carboxy-terminal domain,
RNA polymerase II, polypeptide A)
small phosphatase 2
Molecular function Biologic process unknown; cellular component
unknown; hydrolase activity; molecular function
unknown; nucleus; phosphoprotein phosphatase
activity; soluble fraction
209027_s_at 10006 Spectrin SH3 domain–binding
protein 1
Molecular function Biologic process unknown; cellular component
unknown; molecular function unknown
209273_s_at 81689 HESB-like domain containing 2 Molecular function Molecular function unknown
209274_s_at 81689 HESB-like domain containing 2 Molecular function Molecular function unknown
209964_s_at 6314 Spinocerebellar ataxia 7
(olivopontocerebellar atrophy
with retinal degeneration)
Molecular function Molecular function unknown; nuclear organization
and biogenesis; nucleus; visual perception
210598_at 53345 Transmembrane 6 superfamily
member 2
Molecular function Biologic process unknown; cell adhesion; hyaluronic
acid binding; integral to membrane; molecular
function unknown
211509_s_at 57142 Reticulon 4 Molecular function Endoplasmic reticulum; integral to endoplasmic
reticulum membrane; molecular function unknown;
negative regulation of antiapoptosis; negative
regulation of axon extension; nuclear membrane;
protein binding; regulation of apoptosis
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
211833_s_at 581 BCL2-associated X protein Molecular function Apoptosis; apoptotic mitochondrial changes; cellular
component unknown; germ-cell development;
induction of apoptosis; induction of apoptosis
by extracellular signals; integral to membrane;
molecular function unknown; negative regulation
of cell cycle; negative regulation of survival gene
product activity; regulation of apoptosis
212158_at 6383 Syndecan 2 (heparan sulfate
proteoglycan 1, cell surface–
associated, fibroglycan)
Molecular function Biologic process unknown; cytoskeletal protein
binding; integral to plasma membrane; molecular
function unknown
212284_x_at 7178 Tumor protein, translationally
controlled 1
Molecular function Cytoplasm; extracellular space; molecular function
unknown
212313_at 91782 Hypothetical protein MGC29816 Molecular function Molecular function unknown
214109_at 987 Lipopolysaccharide-responsive vesicle
trafficking, beach-and-anchor –
containing
Molecular function Biologic process unknown; cellular component
unknown; molecular function unknown
216115_at 4763 Neurofibromin 1 (neurofibromatosis,
von Recklinghausen disease,
Watson disease)
Molecular function RAS protein signal transduction; Ras GTPase
activator activity; biologic process unknown;
cell growth and/or maintenance; cellular
component unknown; cytoplasm; enzyme
inhibitor activity; molecular function unknown;
negative regulation of cell cycle; negative
regulation of cell proliferation
217722_s_at 51335 Mesenchymal stem cell protein DSC92 Molecular function Molecular function unknown; neuron differentiation;
nucleus
217743_s_at 55754 Chromosome 6, open reading
frame 67
Molecular function Membrane; molecular function unknown
218080_x_at 11124 Fas (TNFRSF6) –associated
factor 1
Molecular function Apoptosis; cellular component unknown; molecular
function unknown; nucleus
218177_at 57132 CHMP1.5 protein Molecular function Molecular function unknown
218178_s_at 57132 CHMP1.5 protein Molecular function Molecular function unknown
218461_at 51184 Protein x 0004 Molecular function ATP binding; molecular function unknown
218558_s_at 54148 Mitochondrial ribosomal protein L39 Molecular function Biologic process unknown; mitochondrial ribosome;
mitochondrion; molecular function unknown;
structural constituent of ribosome
218799_at 54707 Hypothetical protein FLJ10349 Molecular function ATP binding; molecular function unknown
221012_s_at 81603 Tripartite motif – containing 8 Molecular function Biologic process unknown; cellular component
unknown; molecular function unknown; nucleus;
zinc ion binding
221771_s_at 54737 M-phase phosphoprotein, mpp8 Molecular function Cell cycle; cytoplasm; molecular function unknown;
nucleus
222522_x_at 55173 Mitochondrial ribosomal protein S10 Molecular function Biologic process unknown; intracellular; mitochondrial
ribosome; mitochondrion; molecular function
unknown; protein biosynthesis; ribosome;
structural constituent of ribosome
222907_x_at 757 Chromosome 21, open reading
frame 4
Molecular function Biologic process unknown; integral to membrane;
molecular function unknown
223132_s_at 81603 Tripartite motif – containing 8 Molecular function Biologic process unknown; cellular component
unknown; molecular function unknown; nucleus;
zinc ion binding
223320_s_at 23456 ATP-binding cassette, subfamily B
(MDR/TAP), member 10
Molecular function ATP binding; ATP-binding cassette transporter activity;
biologic process unknown; cellular component
unknown; inner membrane; integral to membrane;
mitochondrion; molecular function unknown;
nucleotide binding; transport
223474_at 64207 Chromosome 14, open reading
frame 4
Molecular function Biologic process unknown; molecular function
unknown; nucleus
223729_at 27443 Cat eye syndrome chromosome
region, candidate 2
Molecular function Cellular component unknown; cytokinesis;
cytoskeleton organization and biogenesis; molecular
function unknown; vesicle-mediated transport
223907_s_at 54984 PIN2-interacting protein 1 Molecular function Cellular component unknown; chromosome, telomeric
region; molecular function unknown; negative
regulation of cell cycle; negative regulation of
cell proliferation; nucleic acid binding; nucleus;
telomerase-dependent telomere maintenance
224281_s_at 51335 Mesenchymal stem cell protein DSC92 Molecular function Molecular function unknown; neuron differentiation;
nucleus
224564_s_at 10313 Reticulon 3 Molecular function Endoplasmic reticulum; extracellular space; integral
to membrane; molecular function unknown
224948_at 64951 Mitochondrial ribosomal protein S24 Molecular function Biologic process unknown; mitochondrial small
ribosomal subunit; mitochondrion; molecular
function unknown; structural constituent of
ribosome
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
225181_at 57492 AT-rich interactive domain
1B (SWI1-like)
Molecular function DNA binding; SWI/SNF complex; biologic process
unknown; cellular component unknown;
chromatin-mediated maintenance of transcription;
intracellular; molecular function unknown; protein
binding; transcription coactivator activity
225309_at 84844 PHD finger protein 5A Molecular function Molecular function unknown
225811_at 10944 Small acidic protein Molecular function Biologic process unknown; cellular component
unknown; molecular function unknown
230265_at 6400 sel-1 suppressor of lin-12– like
(Caenorhabditis elegans)
Molecular function Integral to membrane; molecular function unknown
232591_s_at 55754 Chromosome 6, open reading
frame 67
Molecular function Membrane; molecular function unknown
235907_at 55161 Hypothetical protein FLJ10525 Molecular function Integral to membrane; molecular function unknown
236715_x_at 55075 Uveal autoantigen with coiled-coil
domains and ankyrin repeats
Molecular function Biologic process unknown; extracellular; molecular
function unknown
239726_at 288 Ankyrin 3, node of Ranvier
(ankyrin G)
Molecular function Golgi apparatus; cellular component unknown;
cytoskeletal anchoring; cytoskeleton; endoplasmic
reticulum; molecular function unknown; protein
targeting; signal transduction; structural constituent
of cytoskeleton
242669_at 51569 Hypothetical protein BM-002 Molecular function Molecular function unknown
41047_at 79095 Chromosome 9, open reading
frame 16
Molecular function Biologic process unknown; cellular component
unknown; molecular function unknown
Record count = 62
Establishment and/or maintenance of chromatin architecture
201483_s_at 6827 Suppressor of Ty 4 homolog 1
(S. cerevisiae)
Biologic process Chromatin remodeling; nucleus; regulation of
transcription from Pol II promoter; transcription;
transcription factor activity
201518_at 10951 Chromobox homolog 1 (HP1
b homolog Drosophila)
Biologic process Chromatin; chromatin assembly/disassembly; chromatin
binding; nuclear heterochromatin; nucleoplasm
202265_at 648 B-lymphoma Mo-MLV insertion region
(mouse)
Biologic process Cell growth and/or maintenance; chromatin
modification; nucleus; regulation of transcription,
DNA-dependent; segment specification
203428_s_at 25842 ASF1 anti –silencing function 1
homolog A (S. cerevisiae)
Biologic process Chromatin binding; loss of chromatin silencing;
nucleus
203845_at 8850 p300/CBP–associated factor Biologic process N-Acetyltransferase activity; cell cycle; cell cycle
arrest; chromatin remodeling; histone deacetylase
activity; negative regulation of cell proliferation;
nucleus; protein amino acid acetylation; regulation
of transcription, DNA-dependent; transcription
cofactor activity; transferase activity
209069_s_at 3021 H3 histone, family 3B (H3.3B) Biologic process DNA binding; chromosome; chromosome organization
and biogenesis (sensu Eukarya); nucleosome;
nucleosome assembly; nucleus
212997_s_at 11011 Tousled-like kinase 2 Biologic process ATP binding; cell cycle; chromatin modification;
intracellular signaling cascade; nucleus; protein
amino acid phosphorylation; protein serine/threonine
kinase activity; regulation of chromatin assembly/
disassembly; response to DNA damage stimulus;
transferase activity
213048_s_at 6418 SET translocation (myeloid
leukemia–associated)
Biologic process DNA binding; DNA replication; cell growth and/or
maintenance; nucleosome assembly; nucleus;
protein phosphatase inhibitor activity
213837_at 26013 l(3)mbt– like (Drosophila) Biologic process Chromatin modification; nucleus; regulation of
transcription, DNA-dependent; transcription factor
activity
215373_x_at 57108 PR/SET domain–containing protein 07 Biologic process Chromatin modification; histone-lysine
N-methyltransferase activity; methyltransferase
activity; nucleus; transferase activity
221820_s_at 84148 MYST histone acetyltransferase 1 Biologic process Chromatin; chromatin assembly/disassembly;
chromatin binding; nucleus; transferase activity
222413_s_at 58508 Myeloid/lymphoid or mixed-lineage
leukemia 3
Biologic process DNA binding; chromatin modification; histone-lysine
N-methyltransferase activity; methyltransferase
activity; nucleus; regulation of transcription,
DNA-dependent; transferase activity
224591_at 50809 HP1-BP74 Biologic process DNA binding; nucleosome; nucleosome assembly;
nucleus
225181_at 57492 AT-rich interactive domain 1B
(SWI1-like)
Biologic process DNA binding; SWI/SNF complex; biologic process
unknown; cellular component unknown;
chromatin-mediated maintenance of transcription;
intracellular; molecular function unknown;
protein binding; transcription coactivator activity
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
225951_s_at 1106 Chromodomain helicase DNA-binding
protein 2
Biologic process ATP binding; ATP-dependent DNA helicase activity;
chromatin; chromatin assembly/disassembly;
chromatin binding; chromosome organization
and biogenesis (sensu Eukarya); helicase
activity; hydrolase activity; nucleus; regulation
of transcription from Pol II promoter
226840_at 9555 H2A histone family, member Y Biologic process DNA binding; chromosome; chromosome organization
and biogenesis (sensu Eukarya); nucleosome;
nucleosome assembly; nucleus
227679_at 79885 Histone deacetylase 11 Biologic process Chromatin modification; cytoplasm; histone deacetylase
activity; histone deacetylase complex; hydrolase
activity; nucleus; regulation of transcription,
DNA-dependent; transcription factor binding
229593_at 9555 H2A histone family, member Y Biologic process DNA binding; chromosome; chromosome organization
and biogenesis (sensu Eukarya); nucleosome;
nucleosome assembly; nucleus
231764_at 54108 Chromatin accessibility complex 1 Biologic process DNA binding; chromatin accessibility complex;
chromatin remodeling; e DNA polymerase activity;
e DNA polymerase complex; nucleus
239585_at 8850 p300/CBP–associated factor Biologic process N-Acetyltransferase activity; cell cycle; cell cycle
arrest; chromatin remodeling; histone deacetylase
activity; negative regulation of cell proliferation;
nucleus; protein amino acid acetylation; regulation
of transcription, DNA-dependent; transcription
cofactor activity; transferase activity
40189_at 6418 SET translocation (myeloid
leukemia–associated)
Biologic process DNA binding; DNA replication; cell growth and/or
maintenance; nucleosome assembly; nucleus;
protein phosphatase inhibitor activity
Record count = 21
Small protein–conjugating enzyme activity
200669_s_at 7323 Ubiquitin-conjugating enzyme E2D 3
(UBC4/5 homolog, yeast)
Molecular function Ligase activity; ubiquitin-conjugating enzyme activity;
ubiquitin cycle; ubiquitin-dependent protein
catabolism; ubiquitin-protein ligase activity
200676_s_at 7332 Ubiquitin-conjugating enzyme E2L 3 Molecular function Enzyme binding; ligase activity; ubiquitin-conjugating
enzyme activity; ubiquitin cycle; ubiquitin ligase
complex; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
201344_at 7322 Ubiquitin-conjugating enzyme E2D 2
(UBC4/5 homolog, yeast)
Molecular function Ligase activity; ubiquitin-conjugating enzyme activity;
ubiquitin cycle; ubiquitin-dependent protein
catabolism; ubiquitin-protein ligase activity
201899_s_at 7319 Ubiquitin-conjugating enzyme E2A
(RAD6 homolog)
Molecular function Ligase activity; nucleus; postreplication repair;
ubiquitin-conjugating enzyme activity; ubiquitin
cycle; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
202334_s_at 7320 Ubiquitin-conjugating enzyme E2B
(RAD6 homolog)
Molecular function Ligase activity; nucleus; postreplication repair;
ubiquitin-conjugating enzyme activity; ubiquitin
cycle; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
210024_s_at 10477 Ubiquitin-conjugating enzyme E2E 3
(UBC4/5 homolog, yeast)
Molecular function Ligase activity; ubiquitin-conjugating enzyme activity;
ubiquitin cycle; ubiquitin-protein ligase activity
213535_s_at 7329 Ubiquitin-conjugating enzyme E2I
(UBC9 homolog, yeast)
Molecular function Ligase activity; synaptonemal complex;
ubiquitin-conjugating enzyme activity; ubiquitin
cycle; ubiquitin-dependent protein catabolism;
ubiquitin-protein ligase activity
217978_s_at 55585 Ubiquitin-conjugating enzyme E2Q
(putative)
Molecular function Ubiquitin-conjugating enzyme activity; ubiquitin cycle
224635_s_at 57448 Baculoviral IAP repeat –containing
6 (apollon)
Molecular function Antiapoptosis; apoptosis; cellular component unknown;
cysteine protease inhibitor activity; intracellular;
ligase activity; ubiquitin-conjugating enzyme activity;
ubiquitin cycle
225209_s_at 118424 Ubiquitin-conjugating enzyme E2,
J2 (UBC6 homolog, yeast)
Molecular function Ligase activity; ubiquitin-conjugating enzyme activity;
ubiquitin cycle; ubiquitin-protein ligase activity
230411_at 7336 Ubiquitin-conjugating enzyme E2
variant 2
Molecular function Cell proliferation; ligase activity; protein polyubiquitination;
regulation of DNA repair; regulation of cell cycle;
ubiquitin-conjugating enzyme activity; ubiquitin
cycle; ubiquitin-protein ligase activity
Record count = 11
Heterogeneous nuclear ribonucleoprotein complex
200593_s_at 3192 Heterogeneous nuclear
ribonucleoprotein U (scaffold
attachment factor A)
Cellular component ATP binding; DNA binding; RNA binding; RNA
processing; heterogeneous nuclear ribonucleoprotein
complex; nucleoplasm
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
200775_s_at 3190 Heterogeneous nuclear
ribonucleoprotein K
Cellular component DNA binding; RNA binding; RNA processing;
heterogeneous nuclear ribonucleoprotein complex;
nucleoplasm
201054_at 10949 Heterogeneous nuclear
ribonucleoprotein A0
Cellular component RNA binding; heterogeneous nuclear ribonucleoprotein
complex; mRNA processing
209068_at 9987 Heterogeneous nuclear
ribonucleoprotein D– like
Cellular component RNA binding; RNA processing; double-stranded
DNA binding; heterogeneous nuclear
ribonucleoprotein complex; nucleic acid binding;
poly(A) binding; single-stranded DNA binding;
viral nucleocapsid
213762_x_at 27316 RNA-binding motif protein,
X-linked
Cellular component RNA binding; biologic process unknown; heterogeneous
nuclear ribonucleoprotein complex
221860_at 3191 Heterogeneous nuclear
ribonucleoprotein L
Cellular component RNA binding; heterogeneous nuclear ribonucleoprotein
complex; mRNA processing; nucleoplasm
227110_at 3183 Heterogeneous nuclear
ribonucleoprotein C (C1/C2)
Cellular component RNA binding; RNA splicing; heterogeneous nuclear
ribonucleoprotein complex
235603_at 3192 Heterogeneous nuclear
ribonucleoprotein U (scaffold
attachment factor A)
Cellular component ATP binding; DNA binding; RNA binding; RNA
processing; heterogeneous nuclear ribonucleoprotein
complex; nucleoplasm
Record count = 8
DNA packaging
201483_s_at 6827 Suppressor of Ty 4 homolog 1
(S. cerevisiae)
Biologic process Chromatin remodeling; nucleus; regulation of
transcription from Pol II promoter; transcription;
transcription factor activity
201518_at 10951 Chromobox homolog 1 (HP1
b homolog Drosophila)
Biologic process Chromatin; chromatin assembly/disassembly;
chromatin binding; nuclear heterochromatin;
nucleoplasm
202265_at 648 B-lymphoma Mo-MLV insertion
region (mouse)
Biologic process Cell growth and/or maintenance; chromatin
modification; nucleus; regulation of transcription,
DNA-dependent; segment specification
203428_s_at 25842 ASF1 anti –silencing function 1
homolog A (S. cerevisiae)
Biologic process Chromatin binding; loss of chromatin silencing;
nucleus
203845_at 8850 p300/CBP–associated factor Biologic process N-Acetyltransferase activity; cell cycle; cell
cycle arrest; chromatin remodeling; histone
deacetylase activity; negative regulation of
cell proliferation; nucleus; protein amino
acid acetylation; regulation of transcription,
DNA-dependent; transcription cofactor activity;
transferase activity
209069_s_at 3021 H3 histone, family 3B (H3.3B) Biologic process DNA binding; chromosome; chromosome organization
and biogenesis (sensu Eukarya); nucleosome;
nucleosome assembly; nucleus
212997_s_at 11011 Tousled-like kinase 2 Biologic process ATP binding; cell cycle; chromatin modification;
intracellular signaling cascade; nucleus; protein
amino acid phosphorylation; protein serine/threonine
kinase activity; regulation of chromatin assembly/
disassembly; response to DNA damage stimulus;
transferase activity
213048_s_at 6418 SET translocation (myeloid
leukemia–associated)
Biologic process DNA binding; DNA replication; cell growth and/or
maintenance; nucleosome assembly; nucleus;
protein phosphatase inhibitor activity
213837_at 26013 l(3)mbt– like (Drosophila) Biologic process Chromatin modification; nucleus; regulation of
transcription, DNA-dependent; transcription factor
activity
215373_x_at 57108 PR/SET domain–containing
protein 07
Biologic process Chromatin modification; histone-lysine
N-methyltransferase activity; methyltransferase
activity; nucleus; transferase activity
221820_s_at 84148 MYST histone acetyltransferase 1 Biologic process Chromatin; chromatin assembly/disassembly;
chromatin binding; nucleus; transferase activity
222413_s_at 58508 Myeloid/lymphoid or mixed-lineage
leukemia 3
Biologic process DNA binding; chromatin modification;
histone-lysine N-methyltransferase activity;
methyltransferase activity; nucleus; regulation
of transcription, DNA-dependent; transferase
activity
224591_at 50809 HP1-BP74 Biologic process DNA binding; nucleosome; nucleosome assembly;
nucleus
225181_at 57492 AT-rich interactive domain
1B (SWI1-like)
Biologic process DNA binding; SWI/SNF complex; biologic
process unknown; cellular component
unknown; chromatin-mediated maintenance
of transcription; intracellular; molecular function
unknown; protein binding; transcription
coactivator activity
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
225951_s_at 1106 Chromodomain helicase DNA-binding
protein 2
Biologic process ATP binding; ATP-dependent DNA helicase activity;
chromatin; chromatin assembly/disassembly;
chromatin binding; chromosome organization
and biogenesis (sensu Eukarya); helicase
activity; hydrolase activity; nucleus; regulation
of transcription from Pol II promoter
226447_at 55870 Ash1 (absent, small, or homeotic) – like
(Drosophila)
Biologic process DNA binding; DNA packaging; RNA polymerase II
transcription factor activity; cell – cell signaling;
nucleus; regulation of transcription, DNA-dependent;
tight junction; transcription from Pol II promoter
226840_at 9555 H2A histone family, member Y Biologic process DNA binding; chromosome; chromosome organization
and biogenesis (sensu Eukarya); nucleosome;
nucleosome assembly; nucleus
227679_at 79885 Histone deacetylase 11 Biologic process Chromatin modification; cytoplasm; histone
deacetylase activity; histone deacetylase
complex; hydrolase activity; nucleus; regulation
of transcription, DNA-dependent; transcription
factor binding
229593_at 9555 H2A histone family, member Y Biologic process DNA binding; chromosome; chromosome organization
and biogenesis (sensu Eukarya); nucleosome;
nucleosome assembly; nucleus
231764_at 54108 Chromatin accessibility complex 1 Biologic process DNA binding; chromatin accessibility complex;
chromatin remodeling; e DNA polymerase activity;
e DNA polymerase complex; nucleus
239585_at 8850 p300/CBP–associated factor Biologic process N-Acetyltransferase activity; cell cycle; cell cycle
arrest; chromatin remodeling; histone deacetylase
activity; negative regulation of cell proliferation;
nucleus; protein amino acid acetylation; regulation
of transcription, DNA-dependent; transcription
cofactor activity; transferase activity
40189_at 6418 SET translocation (myeloid
leukemia–associated)
Biologic process DNA binding; DNA replication; cell growth and/or
maintenance; nucleosome assembly; nucleus;
protein phosphatase inhibitor activity
Record count = 22
Small monomeric GTPase activity
200750_s_at 5901 RAN, member RAS oncogene family Molecular function DNA metabolism; GTP binding; RAN small monomeric
GTPase activity; RNA nucleus export; chromatin;
intracellular protein transport; mitotic spindle
assembly; nuclear pore; nucleus; protein transporter
activity; protein nucleus export; regulation of cell
cycle; signal transduction; small GTPase–mediated
signal transduction
202046_s_at 2909 Glucocorticoid receptor DNA-binding
factor 1
Molecular function DNA binding; GTP binding; GTPase activator activity;
negative regulation of cell cycle; negative regulation
of transcription; nucleus; regulation of eye
photoreceptor cell development; regulation of
transcription, DNA-dependent; small GTPase–
mediated signal transduction; small monomeric
GTPase activity; transcriptional repressor activity
202641_at 403 ADP ribosylation factor – like 3 Molecular function G-protein–coupled receptor protein signaling
pathway; GTP binding; signal transducer activity;
small GTPase–mediated signal transduction;
small monomeric GTPase activity
212589_at 22800 Related RAS viral (r-ras) oncogene
homolog 2
Molecular function GTP binding; RAS small monomeric GTPase
activity; cell growth and/or maintenance;
endoplasmic reticulum; plasma membrane;
small GTPase–mediated signal transduction
213404_s_at 6009 Ras homolog enriched in brain Molecular function GTP binding; membrane; signal transduction; small
GTPase–mediated signal transduction; small
monomeric GTPase activity
214435_x_at 5898 v-ral simian leukemia viral oncogene
homolog A (ras-related)
Molecular function GTP binding; chemotaxis; protein binding; signal
transduction; small GTPase–mediated signal
transduction; small monomeric GTPase activity
215506_s_at 9077 Ras homolog gene family, member I Molecular function GTP binding; imprinting; regulation of CDK activity;
small GTPase–mediated signal transduction;
small monomeric GTPase activity
217976_s_at 51143 Dynein, cytoplasmic, light intermediate
polypeptide 1
Molecular function GTP binding; motor activity; small GTPase–mediated
signal transduction; small monomeric GTPase activity
221014_s_at 83452 RAB33B, member RAS oncogene
family
Molecular function GTP binding; Golgi apparatus; RAB small monomeric
GTPase activity; intracellular protein transport;
protein transporter activity; small GTPase–mediated
signal transduction
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
221808_at 9367 RAB9A, member RAS oncogene
family
Molecular function GTP binding; Golgi apparatus; RAB small monomeric
GTPase activity; intracellular protein transport;
protein transporter activity; small GTPase–mediated
signal transduction
222514_at 64121 Ras-related GTP binding C Molecular function GDP binding; RNA splicing; apoptosis; cell growth;
cell growth and/or maintenance; cytoplasm;
heterotrimeric G-protein complex; magnesium ion
binding; nucleus; protein binding; protein
heterodimerization activity; small GTPase–
mediated signal transduction; small monomeric
GTPase activity; transcription
224880_at 5898 v-ral simian leukemia viral oncogene
homolog A (ras-related)
Molecular function GTP binding; chemotaxis; protein binding; signal
transduction; small GTPase–mediated signal
transduction; small monomeric GTPase activity
225930_at 28512 I-nB– interacting Ras-like protein 1 Molecular function GTP binding; NIK-I-nB/NF-nB cascade; cellular
component unknown; small GTPase–mediated signal
transduction; small monomeric GTPase activity
226633_at 51762 RAB8B, member RAS oncogene
family
Molecular function GTP binding; RAB small monomeric GTPase activity;
cellular component unknown; intracellular protein
transport; protein transporter activity; small
GTPase–mediated signal transduction
240111_at 22836 U-Related BTB domain containing 3 Molecular function U small monomeric GTPase activity; biologic process
unknown; intracellular; protein binding
243496_at 22931 RAB18, member RAS oncogene
family
Molecular function GTP binding; RAB small monomeric GTPase activity;
cellular component unknown; endocytosis; intracellular
protein transport; protein transporter activity; small
GTPase–mediated signal transduction
Record count = 16
Negative regulation of apoptosis
202036_s_at 6422 Secreted frizzled– related protein 1 Biologic process Antiapoptosis; development; extracellular space;
membrane; morphogenesis; signal transduction;
transmembrane receptor activity
202443_x_at 4853 Notch homolog 2 (Drosophila) Biologic process Notch signaling pathway; antiapoptosis; calcium
ion binding; cell cycle arrest; cell differentiation;
cell fate determination; cell growth; cell surface;
determination of left/right symmetry; hemopoiesis;
induction of apoptosis; integral to plasma membrane;
ligand-regulated transcription factor activity;
morphogenesis of epithelial sheet; negative
regulation of cell proliferation; neurogenesis;
nucleus; positive regulation of RAS protein
signal transduction; protein binding; protein
heterodimerization activity; receptor activity;
regulation of development; regulation of
transcription, DNA-dependent; stem cell
maintenance; transcription regulator activity
202643_s_at 7128 Tumor necrosis factor-a– induced
protein 3
Biologic process DNA binding; antiapoptosis; apoptosis; negative
regulation of transcription; nucleus; protein binding;
zinc ion binding
208309_s_at 10892 Mucosa-associated lymphoid tissue
lymphoma translocation gene 1
Biologic process Activation of NF-nB– inducing kinase; antiapoptosis;
caspase activity; defense response; intracellular;
peptidase activity; protein binding; proteolysis and
peptidolysis; signal transduction
211509_s_at 57142 Reticulon 4 Biologic process Endoplasmic reticulum; integral to endoplasmic
reticulum membrane; molecular function unknown;
negative regulation of antiapoptosis; negative
regulation of axon extension; nuclear membrane;
protein binding; regulation of apoptosis
211833_s_at 581 BCL2-associated X protein Biologic process Apoptosis; apoptotic mitochondrial changes; cellular
component unknown; germ-cell development;
induction of apoptosis; induction of apoptosis
by extracellular signals; integral to membrane;
molecular function unknown; negative regulation
of cell cycle; negative regulation of survival gene
product activity; regulation of apoptosis
221478_at 665 BCL2/adenovirus E1B 19 kDa
interacting protein 3– like
Biologic process Apoptosis; induction of apoptosis; integral to
membrane; mitochondrion; negative regulation
of survival gene product activity
224635_s_at 57448 Baculoviral IAP repeat –containing 6
(apollon)
Biologic process Antiapoptosis; apoptosis; cellular component
unknown; cysteine protease inhibitor activity;
intracellular; ligase activity; ubiquitin-conjugating
enzyme activity; ubiquitin cycle
Table W2. (continued ).
UNIQID Value Locus Link Gene Name Classification Locus Link Classifications
225984_at 5562 Protein kinase, AMP-activated,
a 1 catalytic subunit
Biologic process ATP binding; activation of MAPK; cAMP-dependent
protein kinase activity; cholesterol biosynthesis;
eukaryotic elongation factor-2 kinase activator
activity; fatty acid biosynthesis; intracellular; negative
regulation of glucosylceramide biosynthesis;
negative regulation of protein biosynthesis; positive
regulation of antiapoptosis; positive regulation
of cholesterol biosynthesis; positive regulation
of fatty acid oxidation; positive regulation of
gluconeogenesis; positive regulation of glucose
import; protein amino acid phosphorylation;
protein serine/threonine kinase activity; response
to hypoxia; transferase activity
37226_at 662 BCL2/adenovirus E1B 19 kDa
interacting protein 1
Biologic process Antiapoptosis; apoptosis; integral to membrane;
protein binding
Record count = 10
Telomerase-dependent telomere maintenance
203449_s_at 7013 Telomeric repeat binding factor
(NIMA-interacting) 1
Biologic process DNA binding; cell cycle; chromosome, telomeric
region; mitosis; nucleus; protein binding;
telomerase-dependent telomere maintenance
209085_x_at 5981 Replication factor C (activator 1) 1;
145 kDa
Biologic process ATP binding; DNA binding; DNA replication factor C
complex; DNA-dependent DNA replication; enzyme
activator activity; nucleotide binding; nucleus;
regulation of transcription, DNA-dependent;
telomerase-dependent telomere maintenance
223907_s_at 54984 PIN2-interacting protein 1 Biologic process Cellular component unknown; chromosome, telomeric
region; molecular function unknown; negative
regulation of cell cycle; negative regulation of
cell proliferation; nucleic acid binding; nucleus;
telomerase-dependent telomere maintenance
Table W2. (continued ).
